About

We conduct clinical trials and observational studies focusing on diabetes identification, management and treatment, including diet and medications. We have specific expertise in new diabetes technologies such as continuous glucose monitoring and the artificial pancreas. 
Affiliation
people
Faculty Position
  • Bergenstal, Richard M., MD, Sr. Research Investigator
  • Carlson, Anders L., MD, Sr. Research Investigator
  • Criego, Amy B., MD, MS, Research Investigator
  • Margolis, Karen L., MD, MPH, Sr. Research Investigator
  • Martens, Thomas W., MD, FACP, Sr. Research Investigator
  • O'Connor, Patrick J., MD, MA, MPH, Sr. Research Investigator
  • Willis, Holly J., PhD, RDN, LD, CDCES, Research investigator
    • Publications While At HealthPartners
    selected publications
    Journal Article
  • A multicenter study of an investigational extended wear insulin infusion set in adults with type 1 diabetes. 
    Diabetes Technology & Therapeutics. 2026
  • Adjunctive treatment with GLP-1 and dual GLP-1/GIP receptor agonists for people with type 1 diabetes: consensus report and practical guidelines for safe use. 
    Diabetes Technology & Therapeutics. 2026
  • Assessing the financial sustainability of a virtual clinic providing comprehensive diabetes care. 
    Journal of Diabetes Science and Technology. 2026
  • CGM-derived efficacy and overall safety of once-weekly insulin efsitora alfa (efsitora) relative to day of administration in adults with type 2 diabetes. 
    Diabetes, Obesity & Metabolism. 2026
  • Cardiovascular risk factors and health-related social needs among youth in a largely rural health system. 
    Academic Pediatrics. 2026
  • Classification and regression tree analysis to understand theory-aligned barriers to glucose self-monitoring behaviors among insulin-using type 2 diabetes patients without continuous glucose monitors. 
    Journal of Health Psychology. 2026
  • Comparative safety of glucose-lowering medications on depression in adults with type 2 diabetes. 
    Diabetes, Obesity & Metabolism. 2026
  • Comparison of the continuous glucose monitoring profiles of four glucose-lowering medications in the GRADE randomized trial. 
    Diabetes care. 2026
  • Duration and characteristics of hypoglycemia with once-weekly insulin efsitora alfa versus once-daily basal insulins in adults with type 2 diabetes: exploratory safety analysis of QWINT 2-4. 
    Diabetes Research and Clinical Practice. 2026
  • Early consideration of automated insulin delivery in type 2 diabetes: a critical review. 
    Endocrine Practice. 2026
  • Evaluation of overall health state, treatment burden, and satisfaction with insulin efsitora alfa (efsitora) vs. daily comparator in adults with type 2 diabetes in the QWINT Clinical Trial Program. 
    Diabetes Therapy. 2026
  • Glycaemic metrics improve significantly within 7 days of continuous glucose monitoring initiation in non-insulin-using people with type 2 diabetes. 
    Diabetes, Obesity & Metabolism. 2026
  • Home blood pressure monitoring in routine care - factors associated with enrollment and blood pressures recorded in the Veterans Health Administration. 
    American Journal of Hypertension. 2026
  • Impact of automated insulin delivery on type 2 diabetes measures. 
    American Journal of Managed Care. 2026
  • Implementation of a clinical decision support tool for hypertension in a rural health system. 
    Journal of the American Medical Informatics Association. 2026
  • Medication adherence and persistence of newly-initiated medications in older adults with diabetes. 
    Journal of the American Pharmacists Association. 2026
  • Older adults benefit from virtual support for continuous glucose monitor use but require longer visits. 
    Journal of Diabetes Science and Technology. 2026
  • Percent time below range is strongly associated with clinically important level 2 hypoglycemia events in individuals with type 1 diabetes. 
    Diabetes Technology & Therapeutics. 2026
  • Population estimates and hypertension and diabetes prevalence: cross-sectional quantitative study comparing electronic health record-derived counts, census, and Centers for Disease Control and Prevention population level analysis and community estimates. 
    JMIR public health and surveillance. 2026
  • Predicting the complex, multilevel ecology of US county-level diabetes prevalence: a cross-sectional, artificial intelligence analysis. 
    Diabetes/Metabolism Research and Reviews. 2026
  • Primary care clinicians' perspectives on an electronic health record-integrated clinical decision support tool for opioid use disorder. 
    J Subst Use Addict Treat. 2026
  • Real-world ketone testing patterns among people using FreeStyle Libre. 
    Diabetes Technology & Therapeutics. 2026
  • Safety and effectiveness of MiniMed™ 780G Advanced Hybrid Closed-Loop use with ultrarapid insulin lispro-AABC in pediatric and adult type 1 diabetes. 
    Diabetes Technology & Therapeutics. 2026
  • Safety and glycemic outcomes of the MiniMed 780G System with a disposable all-in-one sensor. 
    Diabetes Technology & Therapeutics. 2026
  • Staging prediabetes and type 2 diabetes: the time to start is now. 
    The lancet. Diabetes & endocrinology. 2026
  • The glucose monitoring comparison in primary care study (GluCoCare): study design, methods, recruitment success, and baseline characteristics of study participants. 
    Contemporary Clinical Trials. 2026
  • The importance of expanding medicare continuous glucose monitoring coverage for high-risk hypoglycemia. 
    Diabetes Technology & Therapeutics. 2026
  • Trends in utilization of glucagon-like peptide‑1 receptor agonists, sodium-glucose cotransporter‑2 inhibitors, and metabolic bariatric surgery in U.S. adults with diabetes and obesity. 
    Diabetes Research and Clinical Practice. 2026
  • Updated glucose management indicator (GMI) better aligns with HbA(1c) than current GMI: implications for clinical practice and reporting. 
    Diabetologia. 2026
  • Using Nutrition to Improve Time in rangE (UNITE): a randomized clinical trial with continuous glucose monitoring in people with type 2 diabetes not taking insulin. 
    Diabetes Technology & Therapeutics. 2026
  • "Now I can see it works!" Perspectives on using a nutrition-focused approach when initiating continuous glucose monitoring in people with type 2 diabetes: qualitative interview study. 
    JMIR diabetes. 2025
  • A call-to-action to eliminate barriers to accessing automated insulin delivery systems for people with type 1 diabetes. 
    Diabetes Technology & Therapeutics. 2025
  • A nutrition-focused approach during continuous glucose monitoring initiation in people with type 2 diabetes: using a theoretical framework to unite continuous glucose monitoring and food choices. 
    Journal of Diabetes Science and Technology. 2025
  • A randomized controlled trial using continuous glucose monitoring to guide food choices and diabetes self-care in people with type 2 diabetes not taking insulin. 
    Diabetes Technology & Therapeutics. 2025
  • AGP reports for glucose and insulin devices qualitative study: what patients and clinicians want. 
    Sci Diabetes Self Manag Care. 2025
  • Aspirin, cardiovascular events, and major bleeding in older adults: extended follow-up of the ASPREE trial. 
    European Heart Journal. 2025
  • Attitudes towards different weight loss approaches among adults with type 2 diabetes and obesity. 
    Patient Education and Counseling. 2025
  • Automated basal insulin delivery versus multiple daily injections in type 1 diabetes: results from a randomized parallel controlled trial. 
    Frontiers in Endocrinology. 2025
  • Automated insulin delivery in adults with type 2 diabetes: a nonrandomized clinical trial. 
    JAMA network open. 2025
  • Cardiometabolic risk in pediatric patients with intellectual and developmental disabilities. 
    American Journal of Preventive Medicine. 2025
  • Cardiovascular autonomic neuropathy defined by indices of heart rate variability is associated with cardiovascular disease: a longitudinal cohort study of participants with type 1 diabetes. 
    Cardiovascular Diabetology. 2025
  • Clinical and demographic characteristics associated with diabetes remission in six integrated health care systems: a retrospective cohort study. 
    Diabetes care. 2025
  • Clinical decision support and cardiometabolic medication adherence: a randomized clinical trial. 
    JAMA network open. 2025
  • Clinical decision support system for primary care of opioid use disorder: a randomized clinical trial. 
    JAMA internal medicine. 2025
  • Clinical decision support to improve primary care obesity management in adults with diabetes: clinic-randomized study design. 
    Contemporary Clinical Trials. 2025
  • Continuous glucose monitoring. 
    JAMA. 2025
  • Continuous glucose monitoring (CGM) as a behavior modification tool: a case series on CGM-guided nutrition in people with type 2 diabetes not using insulin. 
    Clinical Diabetes. 2025
  • Continuous glucose monitoring data analysis 2.0: functional data pattern recognition and artificial intelligence applications. 
    Journal of Diabetes Science and Technology. 2025
  • Continuous glucose monitoring frequency and glycemic control in people with type 2 diabetes. 
    JAMA network open. 2025
  • Continuous glucose monitoring versus fasting blood glucose basal insulin titration: a retrospective analysis. 
    Diabetes & Metabolic Syndrome. 2025
  • Continuous glucose monitoring-based titration of once-weekly insulin icodec in insulin-naive individuals with type 2 diabetes (onwards 9): a phase 3b, multicenter, single-arm, treat-to-target clinical trial. 
    Diabetes Technology & Therapeutics. 2025
  • Continuous glucose monitoring-measured glucose levels during oral glucose tolerance testing in pregnancy. 
    Diabetes Technology & Therapeutics. 2025
  • Design and protocol of a pragmatic clinical trial to improve cognitive impairment detection in primary care. 
    Contemporary Clinical Trials. 2025
  • Differential associations of somatic and cognitive-affective symptoms of depression with inflammation and insulin resistance: cross-sectional and longitudinal results from the Emotional Distress Sub-Study of the GRADE study. 
    Diabetologia. 2025
  • Differential treatment effects on beta-cell function using model-based parameters in type 2 diabetes: results from the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE). 
    Diabetes care. 2025
  • Effects of continuous glucose monitoring discontinuation in adults with type 2 diabetes not using insulin. 
    Journal of Diabetes Science and Technology. 2025
  • Effects of continuous glucose monitoring versus blood glucose monitoring during a carbohydrate-restricted nutrition intervention in people with type 2 diabetes: 6-month follow-up outcomes from a randomized clinical trial. 
    Endocrine Practice. 2025
  • Exposure to clinical decision support and training increases primary care clinician confidence in managing cognitive impairment care but not confidence to diagnose. 
    BMC Prim Care. 2025
  • GLP-1RA comparative effectiveness against dementia onset relative to other antidiabetic medications in a large, multi-site cohort of patients with type 2 diabetes. 
    Alzheimer's & dementia. 2025
  • Glucose-lowering medication classes and cardiovascular outcomes in patients with type 2 diabetes. 
    JAMA network open. 2025
  • Glucose-lowering medications, glycemia, and cognitive outcomes: the GRADE Randomized Clinical Trial. 
    JAMA internal medicine. 2025
  • Glycaemic outcomes in adults with type 2 diabetes over 34 weeks with the Omnipod® 5 Automated Insulin Delivery System. 
    Diabetes, Obesity & Metabolism. 2025
  • Impact of continuous glucose monitoring versus blood glucose monitoring to support a carbohydrate-restricted nutrition intervention in people with type 2 diabetes. 
    Diabetes Technology & Therapeutics. 2025
  • Incretin mimetics and cardiovascular events - the evolving comparative effectiveness landscape. 
    JAMA network open. 2025
  • Limitations in achieving glycemic targets from CGM data and persistence of severe hypoglycemia in adults with type 1 diabetes regardless of insulin delivery method. 
    Diabetes care. 2025
  • Monitoring ketonemia in people with diabetes: preliminary findings from real-world studies. 
    Diabetes Technology & Therapeutics. 2025
  • Once-weekly insulin efsitora alfa versus once-daily insulin degludec in adults with type 2 diabetes currently treated with basal insulin (QWINT-3): a phase 3, randomised, non-inferiority trial. 
    Lancet (London, England). 2025
  • Patient-reported outcomes improve with a virtual diabetes care model that includes continuous glucose monitoring. 
    Telemedicine Journal and e-Health. 2025
  • Prevalence of diabetes among U.S. refugees and opportunities to improve screening, 2012-2022. 
    Journal of immigrant and minority health. 2025
  • Rapid improvements in glycemic management with use of continuous glucose monitoring in adults with type 2 diabetes treated with basal insulin: 3-month analysis of the MOBILE study. 
    BMJ open diabetes research & care. 2025
  • Retrospective analysis of impact of automated insulin delivery technology on acute care utilisation from 2019 to 2021. 
    Diabetic Medicine. 2025
  • Safety and effectiveness of MiniMed™ 780G advanced hybrid closed-loop insulin intensification in adults with insulin-requiring type 2 diabetes. 
    Diabetes Technology & Therapeutics. 2025
  • The role of ultra-rapid-acting insulin analogs in diabetes: an expert consensus. 
    Journal of Diabetes Science and Technology. 2025
  • Weight gain was associated with worsening glycemia and cardiovascular and kidney outcomes in patients with type 2 diabetes independent of diabetes medication in the GRADE randomized controlled trial. 
    Diabetes care. 2025
  • World Health Organization's guidance for tracking non-communicable diseases towards sustainable development goals 3.4: an initiative for facility-based monitoring. 
    EClinicalMedicine. 2025
  • A CKD clinical decision support system: a cluster randomized clinical trial in primary care clinics. 
    Kidney Med. 2024
  • A comparison of continuous glucose monitoring-measured time-in-range 70-180 mg/dL versus time-in-tight-range 70-140 mg/dL. 
    Diabetes Technology & Therapeutics. 2024
  • A scalable application of artificial intelligence-driven insulin titration program to transform type 2 diabetes management. 
    Diabetes Technology & Therapeutics. 2024
  • Continuous glucose monitoring metrics and hemoglobin A1c relationship in patients with type 2 diabetes treated by hemodialysis. 
    Diabetes Technology & Therapeutics. 2024
  • Continuous glucose monitoring prediction of gestational diabetes mellitus and perinatal complications. 
    Diabetes Technology & Therapeutics. 2024
  • Continuous glucose monitoring profiles in pregnancies with and without gestational diabetes mellitus. 
    Diabetes care. 2024
  • Continuous glucose monitoring-based metrics and the duration of hypoglycaemia events with once-weekly insulin icodec versus once-daily insulin glargine U100 in insulin-naive type 2 diabetes: an exploratory analysis of ONWARDS 1. 
    The lancet. Diabetes & endocrinology. 2024
  • Continuous glucose monitoring-derived differences in pregnancies with and without adverse perinatal outcomes. 
    Obstetrics and Gynecology. 2024
  • Control-IQ technology use in individuals with high insulin requirements: results from the Multicenter Higher-IQ Trial. 
    Journal of Diabetes Science and Technology. 2024
  • Expert panel recommendations for a standardized ambulatory glucose profile report for connected insulin pens. 
    Diabetes Technology & Therapeutics. 2024
  • Frequency and severity of hypoglycemia under conditions of increased hypoglycemic risk with insulin efsitora alfa versus insulin glargine treatment in participants with type 2 diabetes. 
    Diabetes Therapy. 2024
  • Glucose levels measured with continuous glucose monitoring in uncomplicated pregnancies. 
    BMJ open diabetes research & care. 2024
  • Glycemia reduction in type 2 diabetes-hypoglycemia outcomes: a randomized clinical trial. 
    PloS One. 2024
  • Glycemic outcomes persist for up to 2 years in very young children with the Omnipod(®) 5 Automated Insulin Delivery System. 
    Diabetes Technology & Therapeutics. 2024
  • Impact of continuous glucose monitoring on hospitalizations and glucose control in people with type 2 diabetes: real-world analysis. 
    Diabetes, Obesity & Metabolism. 2024
  • Impact of insulin sensitivity and B-cell function over time on glycemic outcomes in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE): differential treatment effects of dual therapy. 
    Diabetes care. 2024
  • Increase access, reduce disparities: recommendations for modifying medicaid CGM coverage eligibility criteria. 
    Journal of Diabetes Science and Technology. 2024
  • Long-term improvements in glycemic control with dexcom CGM use in adults with noninsulin-treated type 2 diabetes. 
    Diabetes Technology & Therapeutics. 2024
  • Once-weekly insulin efsitora alfa versus once-daily insulin degludec in adults with type 1 diabetes (QWINT-5): a phase 3 randomised non-inferiority trial. 
    Lancet (London, England). 2024
  • Pandemic-related practice changes and CVD risk management in community clinics. 
    American Journal of Managed Care. 2024
  • Patient experiences with blood pressure measurement methods for hypertension diagnosis: qualitative findings from the BP-CHECK Study. 
    American Journal of Hypertension. 2024
  • Protocol of a patient randomized clinical trial to improve medication adherence in primary care. 
    Contemporary Clinical Trials. 2024
  • Psychosocial outcomes with the Omnipod® 5 Automated Insulin Delivery System in caregivers of very young children with type 1 diabetes. 
    Diabetes, Obesity & Metabolism. 2024
  • Race and ethnicity and pharmacy dispensing of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes. 
    Lancet Reg Health Am. 2024
  • Randomized pilot of a clinical decision support tool to increase suicide screening for at-risk primary care patients with opioid use disorder. 
    AJPM Focus. 2024
  • Relationship of blood pressure, health behaviors, and new diagnosis and control of hypertension in the BP-CHECK Study. 
    Circulation: Cardiovascular Quality and Outcomes. 2024
  • Severe hypoglycemia and impaired awareness of hypoglycemia persist in people with type 1 diabetes despite use of diabetes technology: results from a cross-sectional survey. 
    Diabetes care. 2024
  • The impact of stimulant medications on blood pressure and body mass index in children with attention deficit hyperactivity disorder. 
    Academic Pediatrics. 2024
  • The use of rescue insulin in the glycemia reduction approaches in diabetes: a comparative effectiveness study (GRADE). 
    Diabetes care. 2024
  • Time in range, time in tight range, and average glucose relationships are modulated by glycemic variability: identification of a glucose distribution model connecting glycemic parameters using real-world data. 
    Diabetes Technology & Therapeutics. 2024
  • Two years with a tubeless automated insulin delivery system: a single-arm multicenter trial in children, adolescents, and adults with Type 1 diabetes. 
    Diabetes Technology & Therapeutics. 2024
  • Unleashing the potential of blood glucose monitoring data with the Ambulatory Glucose Profile Report. 
    Clinical Diabetes. 2024
  • Use of nonsteroidal anti-inflammatory drugs and pancreatic cancer risk in the Women's Health Initiative. 
    Cancer Epidemiology, Biomarkers and Prevention. 2024
  • Virtual care is a double-edged sword: adjusting preventive care service delivery in community health clinics during COVID-19. 
    Journal of family medicine and primary care. 2024
  • A comparison of continuous glucose monitoring estimated hemoglobin A1c in adults with type 1 or type 2 diabetes. 
    Diabetes Technology & Therapeutics. 2023
  • A roadmap to an equitable digital diabetes ecosystem. 
    Endocrine Practice. 2023
  • Acceptability and adherence to home, kiosk, and clinic blood pressure measurement compared to 24-H ambulatory monitoring. 
    Journal of General Internal Medicine. 2023
  • Adapting a clinical decision support system to improve identification of pediatric hypertension in a rural health system: design of a pragmatic trial. 
    Contemporary Clinical Trials. 2023
  • Advancing diabetes quality measurement in the era of continuous glucose monitoring. 
    Sci Diabetes Self Manag Care. 2023
  • All-cause mortality after hypoglycemic and hyperglycemic emergencies among U.S. adults with diabetes, 2011-2020. 
    Diabetes Research and Clinical Practice. 2023
  • Assessing time in range with postprandial glucose-focused titration of ultra rapid lispro (URLi) in people with type 1 diabetes. 
    Diabetes Therapy. 2023
  • Assessment of the glucose management indicator using different sampling durations. 
    Diabetes Technology & Therapeutics. 2023
  • BMI, insulin sensitivity, and cognition in early type 2 diabetes: The Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study. 
    Obesity (Silver Spring, Md.). 2023
  • CVOT Summit 2022 Report: new cardiovascular, kidney, and glycemic outcomes. 
    Cardiovascular Diabetology. 2023
  • Comprehensive telehealth model to support diabetes self-management. 
    JAMA network open. 2023
  • Consensus recommendations for the use of automated insulin delivery technologies in clinical practice. 
    Endocrine Reviews. 2023
  • Continuous glucose monitoring provides durable glycemic benefit in adolescents and young adults with type 1 diabetes: 12-month follow-up results. 
    Pediatric Diabetes. 2023
  • Continuous glucose monitoring-based time-in-range using insulin glargine 300 units/ml versus insulin degludec 100 units/ml in type 1 diabetes: the head-to-head randomized controlled InRange trial. 
    Diabetes, Obesity & Metabolism. 2023
  • Correlation between time in range and HbA1c in people with type 2 diabetes on basal insulin: post hoc analysis of the SWITCH PRO study. 
    Diabetes Therapy. 2023
  • Differential effects of an intervention to reduce cardiovascular risk for patients with bipolar disorder, schizoaffective disorder, or schizophrenia: a randomized clinical trial. 
    Journal of Clinical Psychiatry. 2023
  • Discordance between glucose management indicator and glycated hemoglobin in people without diabetes. 
    Diabetes Technology & Therapeutics. 2023
  • Does clinical decision support increase appropriate medication prescribing for cardiovascular risk reduction?. 
    Journal of the American Board of Family Medicine. 2023
  • Impact of severe hypoglycaemia requiring hospitalization on mortality in people with type 1 diabetes: a national retrospective observational cohort study. 
    Diabetes, Obesity & Metabolism. 2023
  • Improved glycemia with hybrid closed-loop versus continuous subcutaneous insulin infusion therapy: results from a randomized controlled trial. 
    Diabetes Technology & Therapeutics. 2023
  • Increased derived time in range is associated with reduced risk of major adverse cardiovascular events, severe hypoglycemia, and microvascular events in type 2 diabetes: a post hoc analysis of DEVOTE. 
    Diabetes Technology & Therapeutics. 2023
  • Primary care physician beliefs and practices regarding blood pressure measurement: results from BP-CHECK qualitative interviews. 
    BMC Prim Care. 2023
  • Psychosocial outcomes with the Omnipod® 5 automated insulin delivery system in children and adolescents with type 1 diabetes and their caregivers. 
    Pediatric Diabetes. 2023
  • Rates of hypoglycemic and hyperglycemic emergencies among U.S. adults with diabetes, 2011-2020. 
    Diabetes care. 2023
  • Roadmap to the effective use of continuous glucose monitoring in primary care. 
    Diabetes Spectrum. 2023
  • Roadmap to the effective use of continuous glucose monitoring: innovation, investigation, and implementation. 
    Diabetes Spectrum. 2023
  • Roadmaps to continuous glucose monitoring's role in transforming diabetes management. 
    Diabetes Spectrum. 2023
  • Safety and efficacy of the Omnipod 5 Automated Insulin Delivery System in adults with type 2 diabetes: from injections to hybrid closed-loop therapy. 
    Diabetes care. 2023
  • Safety and glycemic outcomes during the MiniMed(TM) advanced hybrid closed-loop system pivotal trial in children and adolescents with type 1 diabetes. 
    Diabetes Technology & Therapeutics. 2023
  • The development and initial feasibility testing of D-HOMES: a behavioral activation-based intervention for diabetes medication adherence and psychological wellness among people experiencing homelessness. 
    Frontiers in Psychology. 2023
  • The relationship between percent time <70 mg/dL and percent time <54 mg/dL measured by continuous glucose monitoring. 
    Diabetes Technology & Therapeutics. 2023
  • A comparison of postprandial glucose control in the Medtronic advanced hybrid closed-loop system versus 670G. 
    Diabetes Technology & Therapeutics. 2022
  • A safe and simple algorithm for adding and adjusting mealtime insulin to basal-only therapy. 
    Clinical Diabetes. 2022
  • Accelerometer-measured daily steps, physical function, and subsequent fall risk in older women: the Objective Physical Activity and Cardiovascular Disease in Older Women Study. 
    Journal of aging and physical activity. 2022
  • Assessing the implementation of a clinical decision support tool in primary care for diabetes prevention: a qualitative interview study using the Consolidated Framework for Implementation Science. 
    BMC Medical Informatics and Decision Making. 2022
  • Association of an automated blood pressure measurement quality improvement program with terminal digit preference and recorded mean blood pressure in 11 clinics. 
    JAMA network open. 2022
  • Automated office blood pressure and the impact of attendance and rest on diagnostic accuracy. 
    American Journal of Hypertension. 2022
  • Benefit of continuous glucose monitoring in reducing hypoglycemia is sustained through 12 months of use among older adults with type 1 diabetes. 
    Diabetes Technology & Therapeutics. 2022
  • Blood pressure checks for diagnosing hypertension: health professionals' knowledge, beliefs, and practices. 
    Journal of the American Board of Family Medicine. 2022
  • Can faster aspart be used to optimize glycemic control with insulin pump therapy? From expectations to lessons learned after a year of use in the United States. 
    Clinical Diabetes. 2022
  • Clinic, home, and kiosk blood pressure measurements for diagnosing hypertension: a randomized diagnostic study. 
    Journal of General Internal Medicine. 2022
  • Clinical decision support with or without shared decision making to improve preventive cancer care: a cluster-randomized trial. 
    Medical Decision Making. 2022
  • Clinician perceptions of a clinical decision support system to reduce cardiovascular risk among prediabetes patients in a predominantly rural healthcare system. 
    BMC Medical Informatics and Decision Making. 2022
  • Comparing patch vs pen bolus insulin delivery in type 2 diabetes using continuous glucose monitoring metrics and profiles. 
    Journal of Diabetes Science and Technology. 2022
  • Continuous glucose monitoring in adults with type 1 diabetes with 35 years duration from the DCCT/EDIC Study. 
    Diabetes care. 2022
  • Continuous ketone monitoring consensus report 2021. 
    Journal of Diabetes Science and Technology. 2022
  • Effect of clinical decision support at community health centers on the risk of cardiovascular disease: a cluster randomized clinical trial. 
    JAMA network open. 2022
  • Effect of clinical decision support on cardiovascular risk among adults with bipolar disorder, schizoaffective disorder, or schizophrenia: a cluster randomized clinical trial. 
    JAMA network open. 2022
  • Effectiveness of BNT162b2 and mRNA-1273 second doses and boosters for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and SARS-CoV-2-related hospitalizations: a statewide report from the Minnesota Electronic Health Record Consortium. 
    Clinical Infectious Diseases. 2022
  • Efficacy of once-weekly tirzepatide versus once-daily insulin degludec on glycaemic control measured by continuous glucose monitoring in adults with type 2 diabetes (SURPASS-3 CGM): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial. 
    The lancet. Diabetes & endocrinology. 2022
  • How introduction of automated insulin delivery systems may influence psychosocial outcomes in adults with type 1 diabetes: findings from the first investigation with the Omnipod® 5 System. 
    Diabetes Research and Clinical Practice. 2022
  • How use of continuous glucose monitoring can address therapeutic inertia in primary care. 
    Postgraduate Medicine. 2022
  • Human papillomavirus vaccination clinical decision support for young adults in an upper midwestern healthcare system: a clinic cluster-randomized control trial. 
    Human Vaccines & Immunotherapeutics. 2022
  • Impact of temporary glycemic target use in the hybrid and advanced hybrid closed-loop systems. 
    Diabetes Technology & Therapeutics. 2022
  • Impact of the COVID-19 pandemic on type 2 diabetes care delivery. 
    Clinical Diabetes. 2022
  • Implementing a prediabetes clinical decision support system in a large primary care system: design, methods, and pre-implementation results. 
    Contemporary Clinical Trials. 2022
  • Interindividual variability in average glucose-glycated haemoglobin relationship in type 1 diabetes and implications for clinical practice. 
    Diabetes, Obesity & Metabolism. 2022
  • Modernizing diabetes care quality measures. 
    Health Affairs. 2022
  • Primary care clinicians' opinions before and after implementation of cancer screening and prevention clinical decision support in a clinic cluster-randomized control trial: a survey research study. 
    BMC Health Services Research. 2022
  • Randomized comparison of self-monitored blood glucose (BGM) versus continuous glucose monitoring (CGM) data to optimize glucose control in type 2 diabetes. 
    Journal of Diabetes and Its Complications. 2022
  • Real-world evidence supporting Tandem Control-IQ Hybrid Closed-Loop success in the Medicare and Medicaid type 1 and type 2 diabetes populations. 
    Diabetes Technology & Therapeutics. 2022
  • Report from the CVOT Summit 2021: new cardiovascular, renal, and glycemic outcomes. 
    Cardiovascular Diabetology. 2022
  • Safety and glycemic outcomes during the MiniMed™ Advanced Hybrid Closed-Loop System Pivotal Trial in adolescents and adults with type 1 diabetes. 
    Diabetes Technology & Therapeutics. 2022
  • Safety and glycemic outcomes with a tubeless automated insulin delivery system in very young children with type 1 diabetes: a single-arm multicenter clinical trial. 
    Diabetes care. 2022
  • Safety and tolerability of high-dose daily vitamin D(3) supplementation in the vitamin D and type 2 diabetes (D2d) study-a randomized trial in persons with prediabetes. 
    European Journal of Clinical Nutrition. 2022
  • Symptomatic diabetic autonomic neuropathy in type 1 diabetes (T1D): findings from the T1D exchange. 
    Journal of Diabetes and Its Complications. 2022
  • The effect of vitamin D supplementation on cardiovascular risk in patients with prediabetes: a secondary analysis of the D2d study. 
    Journal of Diabetes and Its Complications. 2022
  • The optimal duration of a run-in period to initiate continuous glucose monitoring for a randomized trial. 
    Diabetes Technology & Therapeutics. 2022
  • A comparison of two hybrid closed-loop systems in adolescents and young adults with type 1 diabetes (FLAIR): a multicentre, randomised, crossover trial. 
    Lancet (London, England). 2021
  • A pilot study of the functionality and clinician acceptance of a clinical decision support tool to improve primary care of opioid use disorder. 
    Addiction Science & Clinical Practice. 2021
  • Acacia gum is well tolerated while increasing satiety and lowering peak blood glucose response in healthy human subjects. 
    Nutrients. 2021
  • Addressing shortfalls of laboratory HbA(1c) using a model that incorporates red cell lifespan. 
    eLife. 2021
  • Association of cardiovascular outcomes and mortality with sustained long-acting insulin only vs long-acting plus short-acting insulin treatment. 
    JAMA network open. 2021
  • Beyond A1C-standardization of continuous glucose monitoring reporting: why it is needed and how it continues to evolve. 
    Diabetes Spectrum. 2021
  • Continuous glucose monitoring integration for remote diabetes management: virtual diabetes care with case studies. 
    Diabetes Technology & Therapeutics. 2021
  • Design and rationale of an intervention to improve cancer prevention using clinical decision support and shared decision making: a clinic-randomized trial. 
    Contemporary Clinical Trials. 2021
  • Effect of clinical decision support on diagnostic imaging for pediatric appendicitis: a cluster randomized trial. 
    JAMA network open. 2021
  • Effect of continuous glucose monitoring on glycemic control in patients with type 2 diabetes treated with basal insulin: a randomized clinical trial. 
    JAMA. 2021
  • Effect of insulin degludec versus insulin glargine U100 on time in range: SWITCH PRO, a crossover study of basal insulin-treated adults with type 2 diabetes and risk factors for hypoglycaemia. 
    Diabetes, Obesity & Metabolism. 2021
  • Effect of professional CGM (pCGM) on glucose management in type 2 diabetes patients in primary care. 
    Journal of Diabetes Science and Technology. 2021
  • First outpatient evaluation of a tubeless automated insulin delivery system with customizable glucose targets in children and adults with type 1 diabetes. 
    Diabetes Technology & Therapeutics. 2021
  • Flash CGM is associated with reduced diabetes events and hospitalizations in insulin-treated type 2 diabetes. 
    Journal of the Endocrine Society. 2021
  • Glycaemic profiles of diverse patients with type 2 diabetes using basal insulin: MOBILE study baseline data. 
    Diabetes, Obesity & Metabolism. 2021
  • Hypoglycemia and glycemic control in older adults with type 1 diabetes: baseline results from the WISDM Study. 
    Journal of Diabetes Science and Technology. 2021
  • Improved glycemic control in 3,592 adults with type 2 diabetes mellitus initiating a tubeless insulin management system. 
    Diabetes Research and Clinical Practice. 2021
  • Inequities in hypertension control in the United States exposed and exacerbated by COVID-19 and the role of home blood pressure and virtual health care during and after the COVID-19 pandemic. 
    Journal of the American Heart Association. 2021
  • Initiating insulin in the emergency center and urgent care to prevent hospital admission for patients with hyperglycemia: a unique insulin starter kit. 
    Journal of Diabetes Science and Technology. 2021
  • Lived experience of advanced hybrid closed-loop versus hybrid closed-loop: patient-reported outcomes and perspectives. 
    Diabetes Technology & Therapeutics. 2021
  • Long-term efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes: pooled 52-week outcomes from the DEPICT-1 and -2 studies. 
    Diabetes, Obesity & Metabolism. 2021
  • Lost in translation: a disconnect between the science and Medicare coverage criteria for continuous subcutaneous insulin infusion. 
    Diabetes Technology & Therapeutics. 2021
  • Making sense of glucose metrics in diabetes: linkage between postprandial glucose (PPG), time in range (TIR) & hemoglobin A1c (A1C). 
    Postgraduate Medicine. 2021
  • Multicenter trial of a tubeless, on-body automated insulin delivery system with customizable glycemic targets in pediatric and adult participants with type 1 diabetes. 
    Diabetes care. 2021
  • Patient perceptions of using clinical decision support for cancer screening and prevention: "I wouldn't have thought about getting screened without it.". 
    Journal of patient-centered research and reviews. 2021
  • Pragmatic clinic randomized trial to improve chronic kidney disease care: design and adaptation due to COVID disruptions. 
    Contemporary Clinical Trials. 2021
  • Primary care physician perspectives on using team care in clinical practice. 
    Journal of the American Pharmacists Association. 2021
  • Real-world, patient-reported and clinic data from individuals with type 1 diabetes using the MiniMed 670G hybrid closed-loop system. 
    Diabetes Technology & Therapeutics. 2021
  • Recent trends in cardiovascular disease deaths: a state specific perspective. 
    BMC public health. 2021
  • Remote application and use of real-time continuous glucose monitoring by adults with type 2 diabetes in a virtual diabetes clinic. 
    Diabetes Technology & Therapeutics. 2021
  • Renal complications and duration of diabetes: an international comparison in persons with type 1 diabetes. 
    Diabetes Therapy. 2021
  • Sociodemographic, clinical, and treatment-related factors associated with hyperglycemic crises among adults with type 1 or type 2 diabetes in the US from 2014 to 2020. 
    JAMA network open. 2021
  • Switching to once-weekly insulin icodec versus once-daily insulin glargine U100 in type 2 diabetes inadequately controlled on daily basal insulin: a phase 2 randomized controlled trial. 
    Diabetes care. 2021
  • The digital/virtual diabetes clinic: the future Is now-recommendations from an international panel on diabetes digital technologies introduction. 
    Diabetes Technology & Therapeutics. 2021
  • The effect of discontinuing continuous glucose monitoring in adults with type 2 diabetes treated with basal insulin. 
    Diabetes care. 2021
  • The impact of personalized clinical decision support on primary care patients' views of cancer prevention and screening: a cross-sectional survey. 
    BMC Health Services Research. 2021
  • Trial of a new diabetes education model: closing the gap in health disparity for people with diabetes. 
    Journal of Diabetes Science and Technology. 2021
  • Ultrarapid lispro demonstrates similar time in target range to lispro with a hybrid closed-loop system. 
    Diabetes Technology & Therapeutics. 2021
  • Barriers, facilitators, and potential solutions to advancing interoperable clinical decision support: multi-stakeholder consensus recommendations for the opioid use case. 
    AMIA ... Annual Symposium proceedings. AMIA Symposium. 2020
  • Cardiovascular events and costs with home blood pressure telemonitoring and pharmacist management for uncontrolled hypertension. 
    Hypertension (Dallas, Tex.. 2020
  • Challenges involved in establishing a web-based clinical decision support tool in community health centers. 
    Healthcare (Amsterdam, Netherlands). 2020
  • Clinical decision support for recognizing and managing hypertensive blood pressure in youth: no significant impact on medical costs. 
    Academic Pediatrics. 2020
  • Comparison of mortality and major cardiovascular events among adults with type 2 diabetes using human vs analogue insulins. 
    JAMA network open. 2020
  • Design of a pragmatic cluster-randomized trial comparing telehealth care and best practice clinic-based care for uncontrolled high blood pressure. 
    Contemporary Clinical Trials. 2020
  • Diabetes digital app technology: benefits, challenges, and recommendations. A consensus report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group. 
    Diabetologia. 2020
  • Diabetes telehealth solutions: improving self-management through remote initiation of continuous glucose monitoring. 
    Journal of the Endocrine Society. 2020
  • Effect of continuous glucose monitoring on glycemic control in adolescents and young adults with type 1 diabetes: a randomized clinical trial. 
    JAMA. 2020
  • Effect of continuous glucose monitoring on hypoglycemia in older adults with type 1 diabetes: a randomized clinical trial. 
    JAMA. 2020
  • Factors associated with treatment and control of hypertension in a healthy elderly population free of cardiovascular disease: a cross-sectional study. 
    American Journal of Hypertension. 2020
  • Glucose management for exercise using continuous glucose monitoring (CGM) and intermittently scanned CGM (isCGM) systems in type 1 diabetes: position statement of the European Association for the Study of Diabetes (EASD) and of the International Society for Pediatric and Adolescent Diabetes (ISPAD) endorsed by JDRF and supported by the American Diabetes Association (ADA). 
    Pediatric Diabetes. 2020
  • Glucose management for exercise using continuous glucose monitoring (CGM) and intermittently scanned CGM (isCGM) systems in type 1 diabetes: position statement of the European Association for the Study of Diabetes (EASD) and of the International Society for Pediatric and Adolescent Diabetes (ISPAD) endorsed by JDRF and supported by the American Diabetes Association (ADA). 
    Diabetologia. 2020
  • Impact of the 2017 American Heart Association and American College of Cardiology hypertension guideline in aged individuals. 
    Journal of Hypertension. 2020
  • Improving hypertension recognition in adolescents, a small but important first step in cardiovascular disease prevention. 
    Academic Pediatrics. 2020
  • InRange: comparison of the second-generation basal insulin analogues glargine 300 U/mL and degludec 100 U/mL in persons with type 1 diabetes using continuous glucose monitoring-study design. 
    Diabetes Therapy. 2020
  • International Diabetes Center: COVID-19 won't stop us from fulfilling our mission. 
    Journal of Diabetes Science and Technology. 2020
  • Pragmatic trial design of an intervention to reduce cardiovascular risk in people with serious mental illness. 
    Contemporary Clinical Trials. 2020
  • Pre-implementation adaptation of primary care cancer prevention clinical decision support in a predominantly rural healthcare system. 
    BMC Medical Informatics and Decision Making. 2020
  • Predictors of hyperkalemia and hypokalemia in individuals with diabetes: a classification and regression tree analysis. 
    Journal of General Internal Medicine. 2020
  • Self-measured blood pressure monitoring at home: a joint policy statement from the American Heart Association and American Medical Association. 
    Circulation. 2020
  • The effects of financial incentives on diabetes prevention program attendance and weight loss among low-income patients: the We Can Prevent Diabetes cluster-randomized controlled trial. 
    BMC public health. 2020
  • Ultra-rapid lispro improves postprandial glucose control and time in range in type 1 diabetes compared to lispro: PRONTO-T1D Continuous Glucose Monitoring Substudy. 
    Diabetes Technology & Therapeutics. 2020
  • Use of a diabetes-specific nutritional shake to replace a daily breakfast and afternoon snack improves glycemic responses assessed by continuous glucose monitoring in people with type 2 diabetes: a randomized clinical pilot study. 
    BMJ open diabetes research & care. 2020
  • . 2018;41:2275-2280. 
    Diabetes care. 2019
  • Accuracy of self-reported weight in the Women's Health Initiative. 
    Public Health Nutrition. 2019
  • Automated insulin dosing guidance to optimise insulin management in patients with type 2 diabetes: a multicentre, randomised controlled trial. 
    Lancet (London, England). 2019
  • Barriers and facilitators to implementing cancer prevention clinical decision support in primary care: a qualitative study. 
    BMC Health Services Research. 2019
  • Blood pressure checks and diagnosing hypertension (BP-CHECK): design and methods of a randomized controlled diagnostic study comparing clinic, home, kiosk, and 24-hour ambulatory BP monitoring. 
    Contemporary Clinical Trials. 2019
  • Continuous glucose monitoring profiles in healthy nondiabetic participants: a multicenter prospective study. 
    Journal of Clinical Endocrinology and Metabolism. 2019
  • Current status and future directions for electronic point-of-care clinical decision support to improve diabetes management in primary care. 
    Diabetes Technology & Therapeutics. 2019
  • Development of a clinical decision support system for pediatric abdominal pain in emergency department settings across two health systems within the HCSRN. 
    EGEMS (Washington, DC). 2019
  • Efficacy and safety of a morning injection of insulin glargine 300 units/mL versus insulin glargine 100 units/mL in adult patients with type 1 diabetes: a multicentre, randomized controlled trial using continuous glucose monitoring. 
    Diabetes, Obesity & Metabolism. 2019
  • Efficacy and safety of empagliflozin in older patients in the EMPA-REG OUTCOME(R) trial. 
    Age and Ageing. 2019
  • Emphasizing optimal diabetes management for all races/ethnicities, but not race/ethnicity-specific cut points for hemoglobin A1c. 
    JAMA ophthalmology. 2019
  • Evaluation of insulin glargine and exenatide alone and in combination: a randomized clinical trial with continuous glucose monitoring and ambulatory glucose profile analysis. 
    Endocrine Practice. 2019
  • Impact of diabetes and hyperglycemia on health care utilization, infection risk, and survival in patients with cancer receiving glucocorticoids with chemotherapy. 
    Journal of Diabetes and Its Complications. 2019
  • Impact of updated pediatric hypertension guidelines on progression from elevated blood pressure to hypertension in a community-based primary care population. 
    Journal of Clinical Hypertension (Greenwich, Conn.). 2019
  • Implementation of basal-bolus therapy in type 2 diabetes: a randomized controlled trial comparing bolus insulin delivery using an insulin patch with an insulin pen. 
    Diabetes Technology & Therapeutics. 2019
  • Insulin dosing guidance to optimise type 2 diabetes management - authors' reply. 
    Lancet (London, England). 2019
  • PCSK9 inhibitor use in the real world: data From the National Patient-Centered Research Network. 
    Journal of the American Heart Association. 2019
  • Rationale and design for a GRADE substudy of continuous glucose monitoring. 
    Diabetes Technology & Therapeutics. 2019
  • State of type 1 diabetes management and outcomes from the T1D Exchange in 2016-2018. 
    Diabetes Technology & Therapeutics. 2019
  • The association of biochemical hypoglycemia with the subsequent risk of a severe hypoglycemic event: analysis of the DCCT data set. 
    Diabetes Technology & Therapeutics. 2019
  • The relationships between time in range, hyperglycemia metrics, and HbA1c. 
    Journal of Diabetes Science and Technology. 2019
  • Understanding primary care providers' perceptions of cancer prevention and screening in a predominantly rural healthcare system in the upper Midwest. 
    BMC Health Services Research. 2019
  • Validation of time in range as an outcome measure for diabetes clinical trials. 
    Diabetes care. 2019
  • Young children have higher variability of insulin requirements: observations during hybrid closed-loop insulin delivery. 
    Diabetes care. 2019
  • Add-on antihypertensive medications to angiotensin-aldosterone system blockers in diabetes: a comparative effectiveness study. 
    Clinical Journal of the American Society of Nephrology. 2018
  • Alogliptin in patients with type 2 diabetes receiving metformin and sulfonylurea therapies in the EXAMINE Trial. 
    American Journal of Medicine. 2018
  • Association between bariatric surgery and macrovascular disease outcomes in patients with type 2 diabetes and severe obesity. 
    JAMA. 2018
  • Average clinician-measured blood pressures and cardiovascular outcomes in patients with type 2 diabetes mellitus and ischemic heart disease in the EXAMINE Trial. 
    Journal of the American Heart Association. 2018
  • Clinical decision support directed to primary care patients and providers reduces cardiovascular risk: a randomized trial. 
    Journal of the American Medical Informatics Association. 2018
  • Clinical decision support for recognition and management of hypertension: a randomized trial. 
    Pediatrics. 2018
  • Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial. 
    Lancet (London, England). 2018
  • Computer modeling of diabetes and its transparency: a report on the eighth Mount Hood challenge. 
    Value in Health. 2018
  • Cost-effectiveness of a community-based diabetes prevention program with participation incentives for medicaid beneficiaries. 
    Health Services Research. 2018
  • Development and validation of a novel Pediatric Appendicitis Risk Calculator (pARC). 
    Pediatrics. 2018
  • Development of a standardized definition for clinically significant bleeding in the ASPirin in Reducing Events in the Elderly (ASPREE) trial. 
    Contemporary clinical trials communications. 2018
  • Economic evaluation of the home blood pressure telemonitoring and pharmacist case management to control hypertension (Hyperlink) trial. 
    Journal of the American College of Clinical Pharmacy. 2018
  • Effect of aspirin on cardiovascular events and bleeding in the healthy elderly. 
    New England Journal of Medicine. 2018
  • Effect of aspirin on disability-free survival in the healthy elderly. 
    New England Journal of Medicine. 2018
  • Evaluation of an electronic clinical decision support tool for incident elevated BP in adolescents. 
    Academic Pediatrics. 2018
  • Fast-acting insulin aspart versus insulin aspart in the setting of insulin degludec-treated type 1 diabetes: efficacy and safety from a randomized double-blind trial. 
    Diabetes, Obesity & Metabolism. 2018
  • Genetic variants in sex hormone pathways and the risk of type 2 diabetes among African American, Hispanic American, and European American postmenopausal women in the US. 
    Journal of Diabetes. 2018
  • Glucose Management Indicator (GMI): a new term for estimating A1C from continuous glucose monitoring. 
    Diabetes care. 2018
  • Glycaemic control and hypoglycaemia during 12 months of randomized treatment with insulin glargine 300 U/mL versus glargine 100 U/mL in people with type 1 diabetes (EDITION 4). 
    Diabetes, Obesity & Metabolism. 2018
  • High-sensitivity C-reactive protein, low-density lipoprotein cholesterol and cardiovascular outcomes in patients with type 2 diabetes in the EXAMINE (Examination of Cardiovascular Outcomes with Alogliptin versus Standard of Care) trial. 
    Diabetes, Obesity & Metabolism. 2018
  • Key components of success in a randomized trial of blood pressure telemonitoring with medication therapy management pharmacists. 
    Journal of the American Pharmacists Association. 2018
  • Long-term outcomes of the effects of home blood pressure telemonitoring and pharmacist management on blood pressure among adults with uncontrolled hypertension: follow-up of a cluster randomized clinical trial. 
    JAMA network open. 2018
  • Microvascular outcomes in patients with diabetes after bariatric surgery versus usual care: a matched cohort study. 
    Annals of Internal Medicine. 2018
  • Optimal sampling duration for continuous glucose monitoring to determine long-term glycemic control. 
    Diabetes Technology & Therapeutics. 2018
  • Priorities Wizard: chronic disease clinical decision support that works. 
    MetroDoctors. 2018
  • Time savings using a standardized glucose reporting system and ambulatory glucose profile. 
    Journal of Diabetes Science and Technology. 2018
  • Total cardiovascular events analysis of the EXAMINE trial in patients with type 2 diabetes and recent acute coronary syndrome. 
    Clinical Cardiology. 2018
  • Understanding primary care provider attitudes and behaviors regarding cardiovascular disease risk and diabetes prevention in the northern midwest. 
    Clinical Diabetes. 2018
  • 2017;40:777-83. 
    Diabetes care. 2017
  • Assessing the effectiveness of a 3-month day-and-night home closed-loop control combined with pump suspend feature compared with sensor-augmented pump therapy in youths and adults with suboptimally controlled type 1 diabetes: a randomised parallel study protocol. 
    BMJ open. 2017
  • Association of fenofibrate therapy with long-term cardiovascular risk in statin-treated patients with type 2 diabetes. 
    JAMA cardiology. 2017
  • Association of glycemic variability in type 1 diabetes with progression of microvascular outcomes in the Diabetes Control and Complications Trial. 
    Diabetes care. 2017
  • Baseline characteristics of participants in the ASPREE (ASPirin in Reducing Events in the Elderly) Study. 
    Journals of Gerontology. Series A: Biological Sciences and Medical Sciences. 2017
  • Comparison of insulin glargine 300 units/mL and 100 units/mL in adults with type 1 diabetes: continuous glucose monitoring profiles and variability using morning or evening injections. 
    Diabetes care. 2017
  • Consistent findings in glycaemic control, body weight and hypoglycaemia with iGlarLixi (insulin glargine/lixisenatide titratable fixed-ratio combination) vs insulin glargine across baseline HbA1c, BMI and diabetes duration categories in the LixiLan-L trial. 
    Diabetes, Obesity & Metabolism. 2017
  • Continuous glucose monitoring versus usual care in patients with type 2 diabetes receiving multiple daily insulin injections: a randomized trial. 
    Annals of Internal Medicine. 2017
  • Digital health care by in silico glycation of HbA1 blood cells. 
    Journal of Diabetes Science and Technology. 2017
  • Diurnal glucose exposure profiles of patients treated with lixisenatide before breakfast or the main meal of the day: an analysis using continuous glucose monitoring. 
    Diabetes/Metabolism Research and Reviews. 2017
  • Effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes using insulin injections: the DIAMOND Randomized Clinical Trial. 
    JAMA. 2017
  • Effect of initiating use of an insulin pump in adults with type 1 diabetes using multiple daily insulin injections and continuous glucose monitoring (DIAMOND): a multicentre, randomised controlled trial. 
    The lancet. Diabetes & endocrinology. 2017
  • Fast-acting insulin aspart improves glycemic control in basal-bolus treatment for type 1 diabetes: results of a 26-week multicenter, active-controlled, treat-to-target, randomized, parallel-group trial (onset 1). 
    Diabetes care. 2017
  • Financial incentives for diabetes prevention in a Medicaid population: study design and baseline characteristics. 
    Contemporary Clinical Trials. 2017
  • Glucose outcomes with the in-home use of a hybrid closed-loop insulin delivery system in adolescents and adults with type 1 diabetes. 
    Diabetes Technology & Therapeutics. 2017
  • Glycaemic control and hypoglycaemia with insulin glargine 300U/mL versus insulin glargine 100U/mL in insulin-naive people with type 2 diabetes: 12-month results from the EDITION 3 trial. 
    Diabetes and Metabolism. 2017
  • High rates of severe hypoglycemia among African American patients with diabetes: the surveillance, prevention, and Management of Diabetes Mellitus (SUPREME-DM) network. 
    Journal of Diabetes and Its Complications. 2017
  • How to avoid errors in diabetes care. 
    Diabetes Self-Management. 2017
  • Identifying trends in undiagnosed diabetes in U.S. adults by using a confirmatory definition: a cross-sectional study. 
    Annals of Internal Medicine. 2017
  • Liraglutide and renal outcomes in type 2 diabetes. 
    New England Journal of Medicine. 2017
  • Predicting the 6-month risk of severe hypoglycemia among adults with diabetes: development and external validation of a prediction model. 
    Journal of Diabetes and Its Complications. 2017
  • REPLACE-BG: A randomized trial comparing continuous glucose monitoring with and without routine blood glucose monitoring in adults with well-controlled type 1 diabetes. 
    Diabetes care. 2017
  • Racial differences in the relationship of glucose concentrations and hemoglobin A1c levels. 
    Annals of Internal Medicine. 2017
  • Relationship of glycated haemoglobin and reported hypoglycaemia to cardiovascular outcomes in patients with type 2 diabetes and recent acute coronary syndrome events: the EXAMINE trial. 
    Diabetes, Obesity & Metabolism. 2017
  • Response to Comment on Pathak et al. Severe hypoglycemia requiring medical intervention in a large cohort of adults with diabetes receiving care in U.S. integrated health care delivery systems: 2005-2011. 
    Diabetes care. 2017
  • Risk of diabetes after hysterectomy with or without oophorectomy in postmenopausal women. 
    American Journal of Epidemiology. 2017
  • The fallacy of average: how using HbA1c alone to assess glycemic control can be misleading. 
    Diabetes care. 2017
  • The hybrid closed loop therapy system: a step closer to an artificial pancreas. 
    Minn Physician. 2017
  • A randomized trial of a low-fat diet intervention on blood pressure and hypertension: tertiary analysis of the WHI dietary modification trial. 
    American Journal of Hypertension. 2016
  • A substudy evaluating treatment intensification on medication adherence among hypertensive patients receiving home blood pressure telemonitoring and pharmacist management. 
    Journal of Clinical Pharmacy and Therapeutics. 2016
  • Angiotensin-converting enzyme inhibitor use and major cardiovascular outcomes in type 2 diabetes mellitus treated with the dipeptidyl peptidase 4 inhibitor alogliptin. 
    Hypertension (Dallas, Tex.. 2016
  • Cardiovascular mortality in patients with type 2 diabetes and recent acute coronary syndromes from the EXAMINE Trial. 
    Diabetes care. 2016
  • Change in weight status and development of hypertension. 
    Pediatrics. 2016
  • Diabetes, diabetes treatment, and risk of thyroid cancer. 
    Journal of Clinical Endocrinology and Metabolism. 2016
  • Efficacy and safety of LixiLan, a titratable fixed-ratio combination of insulin glargine plus lixisenatide in type 2 diabetes inadequately controlled on basal insulin and metformin: The LixiLan-L randomized trial. 
    Diabetes care. 2016
  • Efficacy and safety of flexible versus fixed dosing intervals of insulin glargine 300 U/mL in people with type 2 diabetes. 
    Diabetes Technology & Therapeutics. 2016
  • Examining failure in a dynamic decision environment: strategies for treating patients with a chronic disease
    2016
  • Factors associated with failure to achieve a glycated haemoglobin target of <8.0% in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. 
    Diabetes, Obesity & Metabolism. 2016
  • Hospital insulin protocol aims for glucose control in glucocorticoid-induced hyperglycemia. 
    Endocrine Practice. 2016
  • Hypoglycemia in older adults with type 1 diabetes. 
    Diabetes Technology & Therapeutics. 2016
  • Liraglutide and cardiovascular outcomes in type 2 diabetes. 
    New England Journal of Medicine. 2016
  • Long-term microvascular disease outcomes in patients with type 2 diabetes after bariatric surgery: evidence for the legacy effect of surgery. 
    Diabetes care. 2016
  • Medication adherence does not explain black-white differences in cardiometabolic risk factor control among insured patients with diabetes. 
    Journal of General Internal Medicine. 2016
  • Orthostatic hypotension in the ACCORD (Action to Control Cardiovascular Risk in Diabetes) blood pressure trial: prevalence, incidence, and prognostic significance. 
    Hypertension (Dallas, Tex.. 2016
  • Pre-existing diabetes and lung cancer prognosis. 
    British Journal of Cancer. 2016
  • Racial differences in and prognostic value of biomarkers of hyperglycemia. 
    Diabetes care. 2016
  • Randomized, double-blind clinical trial comparing basal insulin peglispro and insulin glargine, in combination with prandial insulin lispro, in patients with type 1 diabetes: IMAGINE 3. 
    Diabetes, Obesity & Metabolism. 2016
  • Recurrent endocrine cycles. 
    Journal of Diabetes Science and Technology. 2016
  • Red blood cell fatty acids and incident diabetes mellitus in the women's health initiative memory study. 
    PloS One. 2016
  • Reduction in short-acting insulin requirement accompanies improved glycemic control with basal insulin peglispro compared with insulin glargine in patients with type 1 diabetes. 
    Journal of Diabetes. 2016
  • Relationships between caffeine intake and risk for probable dementia or global cognitive impairment: The Women's Health Initiative Memory Study. 
    Journals of Gerontology. Series A: Biological Sciences and Medical Sciences. 2016
  • Risk factors associated with severe hypoglycemia in older adults with type 1 diabetes. 
    Diabetes care. 2016
  • Safety of a hybrid closed-loop insulin delivery system in patients with type 1 diabetes. 
    JAMA. 2016
  • Severe hypoglycemia requiring medical intervention in a large cohort of adults with diabetes receiving care in U.S. integrated health care delivery systems: 2005-2011. 
    Diabetes care. 2016
  • The effect of treatment of obstructive sleep apnea on glycemic control in type 2 diabetes. 
    American Journal of Respiratory and Critical Care Medicine. 2016
  • A successful multifaceted trial to improve hypertension control in primary care: why did it work?. 
    Journal of General Internal Medicine. 2015
  • Alcohol consumption, body mass index and breast cancer risk by hormone receptor status: Women's Lifestyle and Health Study. 
    BMC cancer. 2015
  • An innovative approach to informing research: gathering perspectives on diabetes care challenges from an online patient community. 
    Interactive journal of medical research. 2015
  • Association between magnesium intake and risk of colorectal cancer among postmenopausal women. 
    Cancer Causes and Control. 2015
  • Clinical utility of SMBG: recommendations on the use and reporting of SMBG in clinical research. 
    Diabetes care. 2015
  • Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D Exchange Clinic registry. 
    Diabetes care. 2015
  • Design of FLAT-SUGAR: randomized trial of prandial insulin versus prandial GLP-1 receptor agonist together with basal insulin and metformin for high-risk type 2 diabetes. 
    Diabetes care. 2015
  • Effects of TZD use and discontinuation on fracture rates in ACCORD Bone Study. 
    Journal of Clinical Endocrinology and Metabolism. 2015
  • Efficacy of liraglutide for weight loss among patients with type 2 diabetes: the SCALE Diabetes Randomized Clinical Trial. 
    JAMA. 2015
  • Factors associated with adherence to blood pressure measurement recommendations at pediatric primary care visits, Minnesota and Colorado, 2007-2010. 
    Preventing Chronic Disease. 2015
  • Glycaemic control and hypoglycaemia with new insulin glargine 300 U/ml versus insulin glargine 100 U/ml in people with type 2 diabetes using basal insulin and oral antihyperglycaemic drugs: the EDITION 2 randomized 12-month trial including 6-month extension. 
    Diabetes, Obesity & Metabolism. 2015
  • Glycemic variability and diabetes complications: does it matter? Simply put, there are better glycemic markers!. 
    Diabetes care. 2015
  • Impact of bariatric surgery on life expectancy in severely obese patients with diabetes: a decision analysis. 
    Annals of Surgery. 2015
  • In Reply to Wayne, Bursuk, McGaphie. 
    Academic Medicine. 2015
  • Individual patient data meta-analysis of self-monitoring of blood pressure (BP-SMART): a protocol. 
    BMJ open. 2015
  • Initiation of human regular U-500 insulin use is associated with improved glycemic control: a real-world US cohort study. 
    BMJ open diabetes research & care. 2015
  • Insulin dose and cardiovascular mortality in the ACCORD Trial. 
    Diabetes care. 2015
  • Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting and research needs. A joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group. 
    Diabetologia. 2015
  • Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting, and research needs: a joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group. 
    Diabetes care. 2015
  • LEADER 2: baseline calcitonin in 9340 people with type 2 diabetes enrolled in the Liraglutide Effect and Action in Diabetes: evaluation of cardiovascular outcome Results (LEADER) trial: preliminary observations. 
    Diabetes, Obesity & Metabolism. 2015
  • Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. 
    Diabetologia. 2015
  • Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. 
    Diabetes care. 2015
  • Methods for engaging stakeholders in comparative effectiveness research: a patient-centered approach to improving diabetes care. 
    Healthcare (Amsterdam, Netherlands). 2015
  • Multicenter observational study of the first-generation intravenous blood glucose monitoring system in hospitalized patients. 
    Journal of Diabetes Science and Technology. 2015
  • New insulin Glargine 300 Units/mL versus Glargine 100 Units/mL in people with type 1 diabetes: a randomized, phase 3a, open-label clinical trial (EDITION 4). 
    Diabetes care. 2015
  • New insulin glargine 300 U/ml compared with glargine 100 U/ml in insulin-naive people with type 2 diabetes on oral glucose-lowering drugs: a randomized controlled trial (EDITION 3). 
    Diabetes, Obesity & Metabolism. 2015
  • Obesity in youth with type 1 diabetes in Germany, Austria, and the United States. 
    Journal of Pediatrics. 2015
  • Pre-existing diabetes and breast cancer prognosis among elderly women. 
    British Journal of Cancer. 2015
  • Predictors of hypoglycemia in the ASPIRE In-Home study and effects of automatic suspension of insulin delivery. 
    Journal of Diabetes Science and Technology. 2015
  • Prevalence of chronic kidney disease among individuals with diabetes in the SUPREME-DM Project, 2005-2011. 
    Journal of Diabetes and Its Complications. 2015
  • Preventable major cardiovascular events associated with uncontrolled glucose, blood pressure, and lipids and active smoking in adults with diabetes with and without cardiovascular disease: a contemporary analysis. 
    Diabetes care. 2015
  • Response to comment on Wong et al. Real-time continuous glucose monitoring among participants in the T1D exchange clinic registry. 
    Diabetes care. 2015
  • Safety and efficacy of insulin therapy delivered via a 4mm pen needle in obese patients with diabetes. 
    Mayo Clinic Proceedings. 2015
  • Sensor-augmented pump and multiple daily injection therapy in the United States and Canada: post-hoc analysis of a randomized controlled trial. 
    Canadian journal of diabetes. 2015
  • TeenBP: development and piloting of an EHR-linked clinical decision support system to improve recognition of hypertension in adolescents. 
    EGEMS (Washington, DC). 2015
  • Trends in diabetes incidence among 7 million insured adults, 2006-2011: the SUPREME-DM project. 
    American Journal of Epidemiology. 2015
  • Who must we target now to minimize future cardiovascular events and total mortality? Lessons from the Surveillance, Prevention and Management of Diabetes Mellitus (SUPREME-DM) cohort study. 
    Circulation: Cardiovascular Quality and Outcomes. 2015
  • A machine learning approach to improving dynamic decision making
    2014
  • A patient-level analysis of efficacy and hypoglycaemia outcomes across treat-to-target trials with insulin glargine added to oral antidiabetes agents in people with type 2 diabetes
    2014
  • Accuracy of hemoglobin A1c imputation using fasting plasma glucose in diabetes research using electronic health records data
    2014
  • Application of PK/PD modeling and simulation to dosing regimen optimization of high-dose human regular U-500 insulin. 
    Journal of Diabetes Science and Technology. 2014
  • Association between diabetes, diabetes treatment and risk of developing endometrial cancer. 
    British Journal of Cancer. 2014
  • Change in physical activity after a diabetes diagnosis: opportunity for intervention. 
    Medicine and Science in Sports and Exercise. 2014
  • Cognitive function and brain structure in persons with type 2 diabetes mellitus after intensive lowering of blood pressure and lipid levels: a randomized clinical trial. 
    JAMA internal medicine. 2014
  • Contrasting weight changes with LY2605541, a novel long-acting insulin, and insulin glargine despite similar improved glycaemic control in T1DM and T2DM. 
    Diabetes, Obesity & Metabolism. 2014
  • Depression in adults in the T1D Exchange Clinic Registry. 
    Diabetes care. 2014
  • Diabetes, diabetes treatment and breast cancer prognosis. 
    Breast Cancer Research and Treatment. 2014
  • Durable change in glycaemic control following intensive management of type 2 diabetes in the ACCORD clinical trial. 
    Diabetologia. 2014
  • Educating resident physicians using virtual case-based simulation improves diabetes management: a randomized controlled trial. 
    Academic Medicine. 2014
  • Intensification of antihyperglycemic therapy among patients with incident diabetes: a Surveillance Prevention and Management of Diabetes Mellitus (SUPREME-DM) study. 
    Pharmacoepidemiology and Drug Safety. 2014
  • Intensive blood pressure control, falls, and fractures in patients with type 2 diabetes: the ACCORD Trial. 
    Journal of General Internal Medicine. 2014
  • LEADER 3--lipase and amylase activity in subjects with type 2 diabetes: baseline data from over 9000 subjects in the LEADER Trial. 
    Pancreas. 2014
  • Lipid screening in children and adolescents in community practice: 2007 to 2010. 
    Circulation: Cardiovascular Quality and Outcomes. 2014
  • Lower glucose variability and hypoglycemia measured by continuous glucose monitoring with novel long-acting insulin LY2605541 versus insulin glargine. 
    Diabetes care. 2014
  • New insulin glargine 300 units/mL versus glargine 100 units/mL in people with type 2 diabetes using oral agents and basal insulin: glucose control and hypoglycemia in a 6-month randomized controlled trial (EDITION 2). 
    Diabetes care. 2014
  • Novel use and utility of integrated electronic health records to assess rates of prediabetes recognition and treatment: brief report from an integrated electronic health records pilot study. 
    Diabetes care. 2014
  • Outcomes of combined cardiovascular risk factor management strategies in type 2 diabetes: the ACCORD randomized trial. 
    Diabetes care. 2014
  • Paradoxical reduction in HDL-C with fenofibrate and thiazolidinedione therapy in type 2 diabetes: the ACCORD Lipid Trial. 
    Diabetes care. 2014
  • Personalised physician learning intervention to improve hypertension and lipid control: randomised trial comparing two methods of physician profiling. 
    BMJ quality & safety. 2014
  • Prescription medication burden in patients with newly diagnosed diabetes: A SUrveillance, PREvention, and ManagEment of Diabetes Mellitus (SUPREME-DM) study. 
    Journal of the American Pharmacists Association. 2014
  • Prevalence of obesity and extreme obesity in children aged 3-5 years. 
    Pediatric Obesity. 2014
  • Randomized trial of telephone outreach to improve medication adherence and metabolic control in adults with diabetes. 
    Diabetes care. 2014
  • Real-time continuous glucose monitoring among participants in the T1D Exchange clinic registry. 
    Diabetes care. 2014
  • Validity of diabetes self-reports in the Women's Health Initiative. 
    Menopause (New York, N.Y.). 2014
  • Within-person variability of urinary bisphenol-A in postmenopausal women. 
    Environmental Research. 2014
  • A multisite study of long-term remission and relapse of type 2 diabetes mellitus following gastric bypass. 
    Obesity Surgery. 2013
  • ASPIRE In-Home: rationale, design, and methods of a study to evaluate the safety and efficacy of automatic insulin suspension for nocturnal hypoglycemia. 
    Journal of Diabetes Science and Technology. 2013
  • Alogliptin after acute coronary syndrome in patients with type 2 diabetes. 
    New England Journal of Medicine. 2013
  • Benefits of early hypertension control on cardiovascular outcomes in patients with diabetes. 
    Diabetes care. 2013
  • Better glycemic control and weight loss with the novel long-acting basal insulin LY2605541 compared with insulin glargine in type 1 diabetes: a randomized, crossover study. 
    Diabetes care. 2013
  • Challenges and future directions of the T1D Exchange Clinic Network and registry. 
    Journal of Diabetes Science and Technology. 2013
  • Comparative effectiveness of bariatric surgery vs. nonsurgical treatment of type 2 diabetes among severely obese adults. 
    Obesity Research & Clinical Practice. 2013
  • Current status and future prospects for electronic point-of-care clinical decision support in diabetes care. 
    Current Diabetes Reports. 2013
  • Design of the liraglutide effect and action in diabetes: evaluation of cardiovascular outcome results (LEADER) trial. 
    American Heart Journal. 2013
  • Determining the influence of type 1 diabetes on two common eating disorder questionnaires. 
    Diabetes Educator. 2013
  • Diabetes mellitus as a risk factor for gastrointestinal cancers among postmenopausal women. 
    Cancer Causes and Control. 2013
  • Differences in the management of type 1 diabetes among adults under excellent control compared with those under poor control in the T1D Exchange Clinic Registry. 
    Diabetes care. 2013
  • Diurnal glucose profiles using continuous glucose monitoring to identify the glucose-lowering characteristics of colesevelam HCl (Welchol). 
    Endocrine Practice. 2013
  • Effect of home blood pressure telemonitoring and pharmacist management on blood pressure control: a cluster randomized clinical trial. 
    JAMA. 2013
  • Evidence of a strong association between frequency of self-monitoring of blood glucose and hemoglobin A1c levels in T1D exchange clinic registry participants. 
    Diabetes care. 2013
  • Exenatide once weekly improved glycaemic control, cardiometabolic risk factors and a composite index of an HbA1c < 7%, without weight gain or hypoglycaemia, over 52 weeks. 
    Diabetes, Obesity & Metabolism. 2013
  • Impact of specific glucose-control strategies on microvascular and macrovascular outcomes in 58,000 adults with type 2 diabetes. 
    Diabetes care. 2013
  • Initial antihyperglycemic drug therapy among 241 327 adults with newly identified diabetes from 2005 through 2010: a surveillance, prevention, and management of diabetes mellitus (SUPREME-DM) study. 
    Annals of Pharmacotherapy. 2013
  • Intensive glycemic control and thiazolidinedione use: effects on cortical and trabecular bone at the radius and tibia. 
    Calcified Tissue International. 2013
  • Longitudinal changes in dietary fat intake and associated changes in cardiovascular risk factors in adults with type 2 diabetes: the ACCORD trial. 
    Diabetes Research and Clinical Practice. 2013
  • Low-volume insulin degludec 200 units/ml once daily improves glycemic control similarly to insulin glargine with a low risk of hypoglycemia in insulin-naive patients with type 2 diabetes: a 26-week, randomized, controlled, multinational, treat-to-target trial: the BEGIN LOW VOLUME trial. 
    Diabetes care. 2013
  • Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials. 
    JAMA. 2013
  • Mortality and morbidity during and after Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial: results by sex. 
    Hypertension (Dallas, Tex.. 2013
  • No racial differences in the association of glycated hemoglobin with kidney disease and cardiovascular outcomes. 
    Diabetes care. 2013
  • Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the Ambulatory Glucose Profile (AGP). 
    Diabetes Technology & Therapeutics. 2013
  • Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the ambulatory glucose profile. 
    Journal of Diabetes Science and Technology. 2013
  • Severe hypoglycemia and diabetic ketoacidosis in adults with type 1 diabetes: results from the T1D Exchange clinic registry. 
    Journal of Clinical Endocrinology and Metabolism. 2013
  • Smoking and diabetes: does the increased risk ever go away?. 
    American Journal of Epidemiology. 2013
  • Smoking cessation, weight change, and coronary heart disease among postmenopausal women with and without diabetes. 
    JAMA. 2013
  • The association of whole grain consumption with incident type 2 diabetes: the Women's Health Initiative Observational Study. 
    Annals of Epidemiology. 2013
  • The authors respond: a multisite study of long-term remission and relapse of type 2 diabetes mellitus following gastric bypass. 
    Obesity Surgery. 2013
  • Threshold-based insulin-pump interruption for reduction of hypoglycemia. 
    New England Journal of Medicine. 2013
  • Using simulation technology to teach diabetes care management skills to resident physicians. 
    Journal of Diabetes Science and Technology. 2013
  • Virtual care: internet-delivered diabetes education for health professionals. 
    Minnesota Physician. 2013
  • A prospective study of leukocyte telomere length and risk of type 2 diabetes in postmenopausal women. 
    Diabetes. 2012
  • A randomized, controlled study of once-daily LY2605541, a novel long-acting basal insulin, versus insulin glargine in basal insulin-treated patients with type 2 diabetes. 
    Diabetes care. 2012
  • Adherence to blood pressure telemonitoring in a cluster-randomized clinical trial. 
    Journal of Clinical Hypertension (Greenwich, Conn.). 2012
  • Advanced meter features improve postprandial and paired self-monitoring of blood glucose in individuals with diabetes: results of the Actions with the CONTOUR Blood Glucose Meter and Behaviors in Frequent Testers (ACT) study. 
    Diabetes Technology & Therapeutics. 2012
  • Are characteristics of the medical home associated with diabetes care costs?. 
    Medical Care. 2012
  • Baseline comparison of three health utility measures and the feeling thermometer among participants in the Action to Control Cardiovascular Risk in Diabetes trial. 
    Cardiovascular Diabetology. 2012
  • Baseline factors associated with glycemic control and weight loss when exenatide twice daily is added to optimized insulin glargine in patients with type 2 diabetes. 
    Diabetes care. 2012
  • Calcium and vitamin D supplementation and cognitive impairment in the women's health initiative. 
    Journal of the American Geriatrics Society. 2012
  • Can a tool that automates insulin titration be a key to diabetes management?. 
    Diabetes Technology & Therapeutics. 2012
  • Characteristics of persons with an eating disorder and type 1 diabetes and psychological comparisons with persons with an eating disorder and no diabetes. 
    International Journal of Eating Disorders. 2012
  • Combined intensive blood pressure and glycemic control does not produce an additive benefit on microvascular outcomes in type 2 diabetic patients. 
    Kidney International. 2012
  • Construction of a multisite DataLink using electronic health records for the identification, surveillance, prevention, and management of diabetes mellitus: the SUPREME-DM project. 
    Preventing Chronic Disease. 2012
  • Cost-effectiveness of an electronic medical record based clinical decision support system. 
    Health Services Research. 2012
  • Depression predicts all-cause mortality: epidemiological evaluation from the ACCORD HRQL substudy. 
    Diabetes care. 2012
  • Design and rationale for Home Blood Pressure Telemonitoring and Case Management to Control Hypertension (HyperLink): a cluster randomized trial. 
    Contemporary Clinical Trials. 2012
  • Diabetes and asthma case identification, validation, and representativeness when using electronic health data to construct registries for comparative effectiveness and epidemiologic research. 
    Medical Care. 2012
  • Diabetes and lung cancer among postmenopausal women. 
    Diabetes care. 2012
  • Diabetes symptoms and distress in ACCORD trial participants: relationship to baseline clinical variables. 
    Clinical Diabetes. 2012
  • Diabetes, metformin, and breast cancer in postmenopausal women. 
    Journal of Clinical Oncology. 2012
  • Dynamic marginal structural modeling to evaluate the comparative effectiveness of more or less aggressive treatment intensification strategies in adults with type 2 diabetes. 
    Pharmacoepidemiology and Drug Safety. 2012
  • Effect of intensive versus standard blood pressure control on depression and health-related quality of life in type 2 diabetes: the ACCORD trial. 
    Diabetes care. 2012
  • Effectiveness of sensor-augmented pump therapy in children and adolescents with type 1 diabetes in the STAR 3 study. 
    Pediatric Diabetes. 2012
  • Effects of exenatide vs. metformin on endothelial function in obese patients with pre-diabetes: a randomized trial. 
    Cardiovascular Diabetology. 2012
  • Efficacy and safety of taspoglutide versus sitagliptin for type 2 diabetes mellitus (T-emerge 4 trial). 
    Diabetes Therapy. 2012
  • Fenofibrate-associated changes in renal function and relationship to clinical outcomes among individuals with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) experience. 
    Diabetologia. 2012
  • Glycaemia and correlates of patient-reported outcomes in ACCORD trial participants. 
    Diabetic Medicine. 2012
  • Health-related quality of life and treatment satisfaction in the Sensor-Augmented Pump Therapy for A1C Reduction 3 (STAR 3) trial. 
    Diabetes Technology & Therapeutics. 2012
  • Intensive glycemic control is not associated with fractures or falls in the ACCORD randomized trial. 
    Diabetes care. 2012
  • Long-term effects of incident diabetes mellitus on cardiovascular outcomes in people treated for hypertension: the ALLHAT Diabetes Extension Study. 
    Circulation: Cardiovascular Quality and Outcomes. 2012
  • Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). 
    Diabetologia. 2012
  • Metabolic outcomes of matched patient populations initiating exenatide BID vs. insulin glargine in an ambulatory care setting. 
    Diabetes, Obesity & Metabolism. 2012
  • Poor cognitive function and risk of severe hypoglycemia in type 2 diabetes: post hoc epidemiologic analysis of the ACCORD trial. 
    Diabetes care. 2012
  • Preadmission glycemic control and changes to diabetes mellitus treatment regimen after hospitalization. 
    Endocrine Practice. 2012
  • The T1D Exchange clinic registry. 
    Journal of Clinical Endocrinology and Metabolism. 2012
  • The Women's Health Initiative: the food environment, neighborhood socioeconomic status, BMI, and blood pressure. 
    Obesity (Silver Spring, Md.). 2012
  • A diet high in low-fat dairy products lowers diabetes risk in postmenopausal women. 
    Journal of Nutrition. 2011
  • Baseline predictors of A1C reduction in adults using sensor-augmented pump therapy or multiple daily injection therapy: the STAR 3 experience. 
    Diabetes Technology & Therapeutics. 2011
  • Biomarker-calibrated dietary energy and protein intake associations with diabetes risk among postmenopausal women from the Women's Health Initiative. 
    American Journal of Clinical Nutrition. 2011
  • Comparison of a novel insulin bolus-patch with pen/syringe injection to deliver mealtime insulin for efficacy, preference, and quality of life in adults with diabetes: a randomized, crossover, multicenter study. 
    Diabetes Technology & Therapeutics. 2011
  • DURATION-2: efficacy and safety of switching from maximum daily sitagliptin or pioglitazone to once-weekly exenatide. 
    Diabetic Medicine. 2011
  • Diabetes performance measures: current status and future directions. 
    Diabetes care. 2011
  • EXamination of cArdiovascular outcoMes with alogliptIN versus standard of carE in patients with type 2 diabetes mellitus and acute coronary syndrome (EXAMINE): a cardiovascular safety study of the dipeptidyl peptidase 4 inhibitor alogliptin in patients with type 2 diabetes with acute coronary syndrome. 
    American Heart Journal. 2011
  • Effects of a low-fat dietary intervention on glucose, insulin, and insulin resistance in the Women's Health Initiative (WHI) Dietary Modification trial. 
    American Journal of Clinical Nutrition. 2011
  • Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy. 
    Lancet Neurology. 2011
  • Exenatide BID Observational Study (ExOS): results for primary and secondary endpoints of a prospective research study to evaluate the clinical effectiveness of exenatide BID use in patients with type 2 diabetes in a real-world setting. 
    Current Medical Research and Opinion. 2011
  • Exenatide BID observational study (ExOS): baseline population characteristics of a prospective research study to evaluate the clinical effectiveness of exenatide bid use in patients with type 2 diabetes in a real-world setting. 
    Current Medical Research and Opinion. 2011
  • Feasibility of measuring gastric emptying time, with a wireless motility device, after subjects consume fiber-matched liquid and solid breakfasts. 
    Appetite. 2011
  • Impact of electronic health record clinical decision support on diabetes care: a randomized trial. 
    Annals of Family Medicine. 2011
  • Improving blood pressure control in individuals with diabetes: a quality improvement collaborative. 
    Joint Commission journal on quality and patient safety. 2011
  • Long-term effect of rosiglitazone and/or ramipril on the incidence of diabetes. 
    Diabetologia. 2011
  • Long-term effects of intensive glucose lowering on cardiovascular outcomes. 
    New England Journal of Medicine. 2011
  • Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications cohort. 
    Archives of Internal Medicine. 2011
  • Missed opportunities in cardiovascular disease prevention?: low rates of hypertension recognition for women at medicine and obstetrics-gynecology clinics. 
    Hypertension (Dallas, Tex.. 2011
  • Near-normalization of glucose and microvascular diabetes complications: data from ACCORD and ADVANCE. 
    Therapeutic Advances in Endocrinology and Metabolism. 2011
  • Prevalence of practice system tools for improving depression care among primary care clinics: the DIAMOND initiative. 
    Journal of General Internal Medicine. 2011
  • Sensor-augmented pump therapy for A1C reduction (STAR 3) study: results from the 6-month continuation phase. 
    Diabetes care. 2011
  • The effect of calcium plus vitamin D on risk for invasive cancer: results of the Women's Health Initiative (WHI) calcium plus vitamin D randomized clinical trial. 
    Nutrition and Cancer. 2011
  • Use of twice-daily exenatide in Basal insulin-treated patients with type 2 diabetes: a randomized, controlled trial. 
    Annals of Internal Medicine. 2011
  • American Diabetes Association. Standards of medical care in diabetes--2010. 
    Diabetes care. 2010
  • Calcium/vitamin D supplementation and coronary artery calcification in the Women's Health Initiative. 
    Menopause (New York, N.Y.). 2010
  • Diabetes and cancer: a consensus report. 
    CA: A Cancer Journal for Clinicians. 2010
  • Diabetes and cancer: a consensus report. 
    Diabetes care. 2010
  • Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. 
    Lancet (London, England). 2010
  • Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. 
    New England Journal of Medicine. 2010
  • Effects of combination lipid therapy in type 2 diabetes mellitus. 
    New England Journal of Medicine. 2010
  • Effects of exenatide combined with lifestyle modification in patients with type 2 diabetes. 
    American Journal of Medicine. 2010
  • Effects of intensive blood-pressure control in type 2 diabetes mellitus. 
    New England Journal of Medicine. 2010
  • Effects of medical therapies on retinopathy progression in type 2 diabetes. 
    New England Journal of Medicine. 2010
  • Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): a randomised trial. 
    Lancet (London, England). 2010
  • Epidemiologic relationships between A1C and all-cause mortality during a median 3.4-year follow-up of glycemic treatment in the ACCORD trial. 
    Diabetes care. 2010
  • Increased risk of bleeding in patients on clopidogrel therapy after drug-eluting stents implantation: insights from the HMO Research Network-Stent Registry (HMORN-stent). 
    Circulation: Cardiovascular Interventions. 2010
  • Incretin-based therapies for the treatment of type 2 diabetes: evaluation of the risks and benefits. 
    Diabetes care. 2010
  • Outpatient EHR-based diabetes clinical decision support that works: lessons learned from implementing Diabetes Wizard. 
    Diabetes Spectrum. 2010
  • Point: The reporting of estimated glucose with hemoglobin A1c. 
    Clinical Chemistry. 2010
  • Simulated physician learning program improves glucose control in adults with diabetes. 
    Diabetes care. 2010
  • The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study. 
    BMJ (Clinical research ed.). 2010
  • The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study. 
    BMJ (Clinical research ed.). 2010
  • The lack of utility of circulating biomarkers of inflammation and endothelial dysfunction for type 2 diabetes risk prediction among postmenopausal women: the Women's Health Initiative Observational Study. 
    Archives of Internal Medicine. 2010
  • Trends in time to confirmation and recognition of new-onset hypertension, 2002-2006. 
    Hypertension (Dallas, Tex.. 2010
  • Using electronic health records to improve outpatient diabetes care. 
    Diabetes Spectrum. 2010
  • A1C predicts type 2 diabetes and impaired glucose tolerance in a population at risk: the community diabetes prevention project. 
    Diabetology & Metabolic Syndrome. 2009
  • ALLHAT findings revisited in the context of subsequent analyses, other trials, and meta-analyses. 
    Archives of Internal Medicine. 2009
  • Comparison of insulin analogue regimens in people with type 2 diabetes mellitus in the PREFER Study: a randomized controlled trial. 
    Diabetes, Obesity & Metabolism. 2009
  • Coronary heart disease in moderately hypercholesterolemic, hypertensive black and non-black patients randomized to pravastatin versus usual care: the antihypertensive and lipid lowering to prevent heart attack trial (ALLHAT-LLT). 
    American Heart Journal. 2009
  • Customized feedback to patients and providers failed to improve safety or quality of diabetes care: a randomized trial. 
    Diabetes care. 2009
  • Detection of hypoglycemia with continuous interstitial and traditional blood glucose monitoring using the FreeStyle Navigator Continuous Glucose Monitoring System. 
    Diabetes Technology & Therapeutics. 2009
  • Diabetes care quality: insurance, health plan, and physician group contributions. 
    American Journal of Managed Care. 2009
  • Disease management strategies to optimize cardiovascular risk in type 2 diabetes mellitus. 
    Current Cardiovascular Risk Reports. 2009
  • Diurnal glucose patterns of exenatide once weekly: a 1-year study using continuous glucose monitoring with ambulatory glucose profile analysis. 
    Endocrine Practice. 2009
  • Does availability of AIR insulin increase insulin use and improve glycemic control in patients with type 2 diabetes?. 
    Diabetes Technology & Therapeutics. 2009
  • Does diabetes double the risk of depression?. 
    Annals of Family Medicine. 2009
  • Efficacy and safety of biphasic insulin aspart 70/30 versus exenatide in subjects with type 2 diabetes failing to achieve glycemic control with metformin and a sulfonylurea. 
    Current Medical Research and Opinion. 2009
  • Heart failure in ALLHAT: did blood pressure medication at study entry influence outcome?. 
    Journal of Clinical Hypertension (Greenwich, Conn.). 2009
  • Is there a downside to customizing care? Implications of general and patient-specific treatment strategies. 
    Journal of Evaluation in Clinical Practice. 2009
  • Low cardiorespiratory fitness in people at risk for type 2 diabetes: early marker for insulin resistance. 
    Diabetology & Metabolic Syndrome. 2009
  • Mindfulness-based stress reduction and diabetes. 
    Diabetes Spectrum. 2009
  • Readiness of US health plans to manage cardiometabolic risk. 
    Preventing Chronic Disease. 2009
  • Simulated physician learning intervention to improve safety and quality of diabetes care: a randomized trial. 
    Diabetes care. 2009
  • The role of diabetes educators in the medical home. 
    Diabetes Spectrum. 2009
  • Adjust to target in type 2 diabetes: comparison of a simple algorithm with carbohydrate counting for adjustment of mealtime insulin glulisine. 
    Diabetes care. 2008
  • Calcium plus vitamin D supplementation and the risk of incident diabetes in the Women's Health Initiative. 
    Diabetes care. 2008
  • Characterizing glucose exposure for individuals with normal glucose tolerance using continuous glucose monitoring and ambulatory glucose profile analysis. 
    Diabetes Technology & Therapeutics. 2008
  • Consensus report of the coalition for clinical research-self-monitoring of blood glucose. 
    Journal of Diabetes Science and Technology. 2008
  • Depression in patients with diabetes: does it impact clinical goals?. 
    Journal of the American Board of Family Medicine. 2008
  • Effect of calcium and vitamin D supplementation on blood pressure: the Women's Health Initiative Randomized Trial. 
    Hypertension (Dallas, Tex.. 2008
  • Effects of estrogen with and without progestin and obesity on symptomatic gastroesophageal reflux. 
    Gastroenterology. 2008
  • Effects of exenatide versus insulin analogues on weight change in subjects with type 2 diabetes: a pooled post-hoc analysis. 
    Current Medical Research and Opinion. 2008
  • Effects of intensive glucose lowering in type 2 diabetes. 
    New England Journal of Medicine. 2008
  • Efficacy and safety of Technosphere inhaled insulin compared with Technosphere powder placebo in insulin-naive type 2 diabetes suboptimally controlled with oral agents. 
    Diabetes care. 2008
  • Improving diabetes care in practice: findings from the TRANSLATE trial. 
    Diabetes care. 2008
  • Low-fat dietary pattern and risk of treated diabetes mellitus in postmenopausal women: the Women's Health Initiative randomized controlled dietary modification trial. 
    Archives of Internal Medicine. 2008
  • The effect of advanced access implementation on quality of diabetes care. 
    Preventing Chronic Disease. 2008
  • Validity of diabetes self-reports in the Women's Health Initiative: comparison with medication inventories and fasting glucose measurements. 
    Clinical Trials (London, England). 2008
  • Variation in quality of diabetes care at the levels of patient, physician, and clinic. 
    Preventing Chronic Disease. 2008
  • Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods. 
    American Journal of Cardiology. 2007
  • Blood pressure control in Hispanics in the antihypertensive and lipid-lowering treatment to prevent heart attack trial. 
    Hypertension (Dallas, Tex.. 2007
  • Circulating levels of endothelial adhesion molecules and risk of diabetes in an ethnically diverse cohort of women. 
    Diabetes. 2007
  • Clinical and public health implications of glycemic relapse in type 2 diabetes. 
    Nature Clinical Practice: Endocrinology & Metabolism. 2007
  • Estrogen therapy and coronary-artery calcification. 
    New England Journal of Medicine. 2007
  • Evolution of the lipid trial protocol of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. 
    American Journal of Cardiology. 2007
  • Health-related quality of life and cost-effectiveness components of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: rationale and design. 
    American Journal of Cardiology. 2007
  • How to avoid errors in diabetes care. 
    Diabetes Self-Management. 2007
  • Recruitment strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. 
    American Journal of Cardiology. 2007
  • Severe hypoglycemia monitoring and risk management procedures in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. 
    American Journal of Cardiology. 2007
  • Are claims data accurate enough to identify patients for performance measures or quality improvement? The case of diabetes, heart disease, and depression. 
    American Journal of Medical Quality. 2006
  • Calcium plus vitamin D supplementation and the risk of colorectal cancer. 
    New England Journal of Medicine. 2006
  • Calcium plus vitamin D supplementation and the risk of fractures. 
    New England Journal of Medicine. 2006
  • Care quality and implementation of the chronic care model: a quantitative study. 
    Annals of Family Medicine. 2006
  • Diabetes: how are we diagnosing and initially managing it?. 
    Annals of Family Medicine. 2006
  • Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). 
    Archives of Internal Medicine. 2006
  • Impact of office systems and improvement strategies on costs of care for adults with diabetes. 
    Diabetes care. 2006
  • Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. 
    JAMA. 2006
  • Low-fat dietary pattern and risk of colorectal cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. 
    JAMA. 2006
  • Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. 
    JAMA. 2006
  • Prospective study of physical activity in different periods of life and the risk of ovarian cancer. 
    International Journal of Cancer. 2006
  • Risk of fracture in women with type 2 diabetes: the Women's Health Initiative Observational Study. 
    Journal of Clinical Endocrinology and Metabolism. 2006
  • Statin use and breast cancer: prospective results from the Women's Health Initiative. 
    Journal of the National Cancer Institute. 2006
  • The business case for diabetes disease management for managed care organizations. 
    Frontiers in health policy research. 2006
  • Treatment models from the International Diabetes Center: advancing from oral agents to insulin therapy in type 2 diabetes. 
    Endocrine Practice. 2006
  • Cholesterol levels and statin use in patients with coronary heart disease treated in primary care settings. 
    Preventing Chronic Disease. 2005
  • Efficacy of inhaled insulin in patients with type 2 diabetes not controlled with diet and exercise: a 12-week, randomized, comparative trial. 
    Diabetes care. 2005
  • Factors driving diabetes care improvement in a large medical group: ten years of progress. 
    American Journal of Managed Care. 2005
  • Impact of an electronic medical record on diabetes quality of care. 
    Annals of Family Medicine. 2005
  • Impact of modem-transferred blood glucose data on clinician work efficiency and patient glycemic control. 
    Diabetes Technology & Therapeutics. 2005
  • Macrovascular risk factors in patients with diabetes: physician treatment strategies and extent of control. 
    Endocrine Practice. 2005
  • Predictors of health care costs in adults with diabetes. 
    Diabetes care. 2005
  • Randomized trial of quality improvement intervention to improve diabetes care in primary care settings. 
    Diabetes care. 2005
  • The QUEST for quality: what are medical groups doing about it?. 
    Joint Commission journal on quality and patient safety. 2005
  • Do all components of the chronic care model contribute equally to quality improvement?. 
    Joint Commission journal on quality and safety. 2004
  • Is patient readiness to change a predictor of improved glycemic control?. 
    Diabetes care. 2004
  • Meeting recommendations for multiple healthy lifestyle factors. Prevalence, clustering, and predictors among adolescent, adult, and senior health plan members. 
    American Journal of Preventive Medicine. 2004
  • Undetected, uncontrolled blood pressure in type 2 diabetes: self-monitored blood pressure profiles. 
    Blood Pressure. 2004
  • Characterizing blood pressure control in individuals with Type 2 diabetes: the relationship between clinic and self-monitored blood pressure. 
    Diabetic Medicine. 2003
  • Clinical impact of prandial state, exercise, and site preparation on the equivalence of alternative-site blood glucose testing. 
    Diabetes care. 2003
  • Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study. 
    JAMA. 2003
  • Use of an automated device for alternative site blood glucose monitoring. 
    Diabetes care. 2001
  • A 16-week comparison of the novel insulin analog insulin glargine (HOE 901) and NPH human insulin used with insulin lispro in patients with type 1 diabetes. 
    Diabetes care. 2000
  • Identifying variables associated with inaccurate self-monitoring of blood glucose: proposed guidelines to improve accuracy. 
    Diabetes Educator. 2000
  • Improving diabetes care in a large health care system: an enhanced primary care approach. 
    Joint Commission Journal on Quality Improvement. 2000
  • Optimization of insulin therapy in patients with type 2 diabetes. 
    Endocrine Practice. 2000
  • Continuous quality improvement can improve glycemic control for HMO patients with diabetes. 
    Archives of Family Medicine. 1996
  • Cost-effectiveness of medical nutrition therapy provided by dietitians for persons with non-insulin-dependent diabetes mellitus. 
    Journal of the American Dietetic Association. 1995
  • Effectiveness of medical nutrition therapy provided by dietitians in the management of non-insulin-dependent diabetes mellitus: a randomized, controlled clinical trial. 
    Journal of the American Dietetic Association. 1995
  • A joint venture with the commonwealth of independent states. 
    Diabetes care. 1993
  • Practice guidelines for nutrition care by dietetics practitioners for outpatients with non-insulin-dependent diabetes mellitus: methodologies for field-testing and cost-effectiveness analysis. 
    Journal of the American Dietetic Association. 1992
  • Observations on C-peptide and free insulin in the blood during continuous subcutaneous insulin infusion and conventional insulin therapy. 
    Diabetes. 1985
  • Observations on blood lipid and intermediary metabolite concentrations during conventional insulin treatment or CSII. 
    Diabetes. 1985
  • Observations on control of glycemia with conventional insulin therapy or continuous subcutaneous insulin infusion. 
    Diabetes. 1985
    • Editorial Article
  • From the ASPREE investigators [editorial]. 
    Clinical Trials (London, England).  22. 2025
  • Insulin management in patients with diabetes receiving hemodialysis: unanswered questions and way forward [editorial]. 
    American Journal of Kidney Diseases.  83. 2024
  • The Glucose Management Indicator: time to change course [editorial]?. 
    Diabetes care.  47. 2024
  • Continuous glucose monitoring for type 2 diabetes: how does it compare with type 1 diabetes [editorial]?. 
    Diabetes Technology & Therapeutics.  24. 2022
  • More green, less red: how color standardization may facilitate effective use of CGM data [editorial]. 
    Journal of Diabetes Science and Technology.  16. 2022
  • Continuous glucose monitoring and glycemic control in patients with type 2 diabetes treated with basal insulin [editorial]. 
    JAMA.  326. 2021
  • Glucose management for exercise using continuous glucose monitoring: should sex and prandial state be additional considerations [editorial]?. 
    Diabetologia.  64. 2021
  • Overcoming therapeutic inertia in type 2 diabetes care-timing, context, and appropriateness of treatment intensification [editorial]. 
    JAMA network open.  4. 2021
  • Continuous glucose monitoring-derived data report-simply a better management tool [editorial]. 
    Diabetes care.  43. 2020
  • Duration of hybrid closed-loop insulin therapy to achieve representative glycemic outcomes in adults with type 1 diabetes [editorial]. 
    Diabetes care.  43. 2020
  • Glucose management indicator (GMI): insights and validation using Guardian 3 and Navigator 2 sensor data [editorial]. 
    Diabetes care.  42. 2019
  • Continuous glucose monitoring: transforming diabetes management step by step [editorial]. 
    Lancet (London, England).  391. 2018
  • Evaluating interventions and titrations using fasting blood glucose [editorial]. 
    Journal of Diabetes Science and Technology.  12. 2018
  • Identifying trends in undiagnosed diabetes in U.S. adults [editorial]. 
    Annals of Internal Medicine.  168. 2018
  • Racial differences in the relationship of glucose concentrations and hemoglobin A1c levels [editorial]. 
    Annals of Internal Medicine.  168. 2018
  • Risk and benefit information and use of aspirin [editorial]. 
    JAMA internal medicine.  177. 2017
  • Strategies to prioritize clinical options in primary care [editorial]. 
    Annals of Family Medicine.  15. 2017
  • Continuous glucose monitoring in patients with type 1 diabetes using insulin injections [editorial]. 
    Diabetes care.  39. 2016
  • Trends in insulin use and diabetes control in the U.S.: 1988-1994 and 1999-2012 [editorial]. 
    Diabetes care.  39. 2016
  • Intensive BP control, falls, and fractures: response to Jolobe [editorial]. 
    Journal of General Internal Medicine.  30. 2015
  • How clinical pharmacists can improve outpatient diabetes care [editorial]. 
    Diabetes Management (London, England).  4. 2014
  • Patients affected by changes to hypertension guideline [editorial]. 
    JAMA.  312. 2014
  • Personalized and prioritized diabetes treatment recommendations to reduce cardiovascular risk [editorial]
    2014
  • Patient preferences in diabetes care: overcoming barriers using new strategies [editorial]. 
    Journal of comparative effectiveness research.  2. 2013
  • Self-reported diabetes is a valid outcome in pragmatic clinical trials and observational studies [editorial]. 
    Journal of Clinical Epidemiology.  66. 2013
  • Threshold insulin-pump interruption to reduce hypoglycemia [editorial]. 
    New England Journal of Medicine.  369. 2013
  • A look ahead at the future of diabetes prevention and treatment [editorial]. 
    JAMA.  308. 2012
  • Greater diabetes-care contact frequency is associated with more rapid achievement of care goals but interpretation of finding requires consideration of patient adherence and motivation [editorial]. 
    Evidence-Based Medicine.  17. 2012
  • How EHR-based clinical decision support promotes patient-centered care [editorial]. 
    Diabetes Management (London, England).  2. 2012
  • Prioritizing treatments in type 2 diabetes mellitus [editorial]. 
    Archives of Internal Medicine.  172. 2012
  • Quality improvement collaboratives in the age of health informatics--new wine in new wineskins [editorial]. 
    BMJ quality & safety.  21. 2012
  • Smoking cessation, weight gain, and risk of type 2 diabetes mellitus among postmenopausal women [editorial]. 
    Archives of Internal Medicine.  172. 2012
  • Opportunities to increase the effectiveness of EHR-based diabetes clinical decision support [invited editorial]. 
    Appl Clin Inf.  2. 2011
  • Strategies to reduce the cost of renal complications in patients with type 2 diabetes [editorial]. 
    Diabetes care.  34. 2011
  • The Women's Health Initiative Calcium/Vitamin D Trial [editorial]. 
    Hypertension (Dallas, Tex..  57. 2011
  • Insulin regimens in type 2 diabetes [editorial]. 
    New England Journal of Medicine.  362. 2010
  • The growing importance of diabetes screening [editorial]. 
    Diabetes care.  33. 2010
  • Integrated practice units are bridges, not 'archipelagoes' [editorial]. 
    Health Affairs.  27. 2008
  • Improving diabetes care by combating clinical inertia [editorial]. 
    Health Services Research.  40. 2005
  • The insulin sliding scale is not dead [editorial]. 
    Archives of Internal Medicine.  158. 1998
    • Chapter
  • Comparative effectiveness of adaptive treatment strategies. 
    Targeted learning in data science: causal inference for complex longitudinal studies (Springer series in statistics). 2018
  • Diabetes. 
    Chronic disease epidemiology and control. 2010
  • SimCare: A Model for Studying Physician Decisionmaking Activity. 
    Advances in Patient Safety: From Research to Implementation (Volume 4: Programs, Tools, and Products). 2005
  • SimCare: a model for studying physician decisionmaking activity. 
    Advances in Patient Safety: From Research to Implementation (Volume 4: Programs, Tools, and Products). 2005
    • Conference Paper
  • Diabetes "smart" registries: context, complexity, and impact
    2019
  • Cost-effectiveness of EMR-based clinical decision support [presentation
    2011
  • Changes in physical activity and nutrition in a behavioral intervention pilot study: Passport to Brain Wellness
    2010
    • Conference Poster
  • Autonomic neuropathy in type 1 diabetes (T1D): findings from the T1D Exchange [poster]
    2019
  • Effect of professional CGM (pCGM) on glucose management in type 2 diabetes patients in primary care [poster]
    2019
  • Factors associated with Diabetes Prevention Program (DPP) compliance and weight loss among low-income participants [poster]
    2019
  • Hybrid closed-loop in adults with type 1 diabetes: impact of baseline A1c on glucose outcomes and insulin delivery [poster]
    2019
  • Low level of agreement in evaluation of continuous glucose monitoring profiles [poster]
    2019
  • Optimal sampling duration of hybrid closed-loop therapy to determine long-term glycemic control in adults with type 1 diabetes [poster]
    2019
  • Comparing patch vs.pen bolus insulin delivery in type 2 diabetes using continuous glucose monitoring metrics and profiles [poster]
    2018
  • Efficacy and safety of faster aspart compared with insulin aspart both with insulin degludec in adults with T1D [poster]
    2018
  • Hypoglycaemia with mealtime fast-acting insulin aspart versis insulin aspart across two large type 1 diabetes trials [poster]
    2018
  • Impact of diabetes and hyperglycemia on health care utilization, infection risk, and survival in patients with cancer receiving glucocorticoids with chemotherapy [poster]
    2018
  • Improved glycemic control with carbohydrate counting for adjustment of fast-acting insulin aspart versus insulin aspart in subjects with type 1 diabetes [poster]
    2018
  • Incidence of diabetes and hyperglycemia among patients receiving glucocorticoids with chemotherapy [poster]
    2018
  • Increased HbA1c variability may shorten time to microalbuminuria development in type 1 diabetes (T1D) [poster]
    2018
  • Optimizing basal-bolus therapy in T2D—a randomized controlled trial comparing bolus insulin delivery using an insulin patch vs. an insulin pen [poster]
    2018
  • Real-world improvement in above-target estimated A1c with sequential use of professional flash continuous glucose monitoring for individuals with diabetes [poster]
    2018
  • A clinical decision support system promotes shared decision-making and cardiovascular risk factor management [poster]
    2017
  • Aspirin for primary prevention of atherosclerotic cardiovascular disease: challenges to appropriate use [poster]
    2017
  • Blood pressure checks and diagnosing hypertension (BP-CHECK): a stakeholder informed randomized controlled diagnostic study comparing clinic, home, kiosk, and 24-hour ambulatory BP monitoring [poster]
    2017
  • Can prioritized clinical decision support in primary care reduce cardiovascular risk? [poster]
    2017
  • Clinical decision support impact on overuse and underuse of aspirin for primary prevention of cardiovascular events [poster]
    2017
  • Impact of improving diabetes care on Quality adjusted Life Expectancy (QALE) and costs: a 40-year perspective [poster]
    2017
  • Long-term outcomes of a cluster-randomized trial testing the effects of blood pressure (BP) telemonitoring and pharmacist management on BP outcomes [poster]
    2017
  • Long-term outcomes of a cluster-randomized trial testing the effects of blood pressure telemonitoring and pharmacist management [poster]
    2017
  • Primary care provider use rates of a clinical decision support tool and change in diabetes performance measures [poster]
    2017
  • Results of a cluster-randomized trial testing the effects of TeenBP, an EHR-based clinical decision support tool, on recognition of adolescent hypertension [poster]
    2017
  • What factors facilitate weight loss among Medicaid beneficiaries participating in the diabetes prevention program [poster]?
    2017
  • Correlation between provider use rates of a clinical decision support tool and diabetes performance measures [e-poster 1266-P]. 
    Diabetes. 2016
  • Pivotal trial of a hybrid closed-loop system in type 1 diabetes (T1D) [poster]
    2016
  • Design of diabetes clinical decision support systems that reduce CV risk [poster]
    2015
  • Improving population health: predictors of recidivism to uncontrolled hypertension in patients with previously well-controlled hypertension [poster]
    2015
  • Passive safety monitoring using electronic medical records data for pragmatic cardiovascular clinical trials [poster]
    2015
  • Reducing staff time with optimized work flows and standardized ambulatory glucose profile (AGP) [poster]
    2015
  • Relation of change in weight status to the development of hypertension in children and adolescents [poster]
    2015
  • How did pharmacists help patients achieve blood pressure control in a randomized trial of home blood pressure telemonitoring plus pharmacist management [poster]?
    2014
  • Timing and impact of transition from pediatric to adult care on glycemic control among adolescents and young adults with diabetes: results from the SUPREME-DM pilot study [poster]
    2014
  • Within-person variability of urinary Bisphenol-A in postmenopausal women [poster]
    2014
  • A multisite study of long-term remission and relapse of type 2 diabetes mellitus following gastric bypass [poster]
    2013
  • Comparative effectiveness of bariatric surgery vs. nonsurgical treatment of type 2 diabetes among severely obese adults [poster]
    2013
  • Comparison of blood pressure (BP) measurement in HealthPartners primary care clinics before and after automated BP device use [poster]
    2013
  • Declining rates of major cardiovascular events in adults with and without diabetes: 2005-2011 [poster]
    2013
  • Diagnosis of pediatric hypertension depends on clinical practice guideline definitions [poster]
    2013
  • Frequency and results of glucose screening in children and adolescents 2007-2011 [poster]
    2013
  • Frequency of CV Wizard use and gender disparity [poster]
    2013
  • Impact of BMI and change in BMI on progression from normotension to prehypertension or hypertension in patients ages 3-17 [poster]
    2013
  • Impact of oral contraceptives on adolescent blood pressure and BMI [poster]
    2013
  • Impact of oral contraceptives on adolescent blood pressure and BMI [poster]
    2013
  • Impact of specific glucose-control strategies on microvascular outcomes in 58,000 adults with type 2 diabetes [poster]
    2013
  • Improved self-efficacy and satisfaction with care among Hyperlink intervention patients [poster]
    2013
  • Improving diabetes management with mindfulness-based stress reduction [poster]
    2013
  • Outcomes at six months of a randomized trial of home blood pressure telemonitoring with pharmacist case management [poster]
    2013
  • Predictors of medication usage for incident diabetes patients: a SUrveillance, PREvention, and ManagEment of Diabetes Mellitus (SUPREME-DM) study [poster]
    2013
  • Prevalence of obesity and extreme obesity in children aged three to five years [poster]
    2013
  • Aspirin decision support using data-driven treatment algorithms [poster]
    2012
  • From research innovation to broader public use: the SimCare story [poster]
    2012
  • Home blood pressure telemonitoring for hypertension management: implications for practice [poster]
    2012
  • Impact of bariatric surgery on life expectancy in adults with diabetes [poster]
    2012
  • Impact of bariatric surgery on life expectancy in adults with diabetes [poster]
    2012
  • Outcomes at six months of a randomized trial of home blood pressure telemonitoring with pharmacist case management [poster]
    2012
  • Simulated provider training improves diabetes management [poster]
    2012
  • Testing a clinical decision support process to lower cardiovascular risk of patients [poster]
    2012
  • A simulated diabetes learning intervention improves provider knowledge and confidence in managing diabetes [poster]
    2011
  • Designing a patient interface for shared decision support [poster]
    2011
  • Provider satisfaction with a simulated learning approach to diabetes management [poster]
    2011
  • Use of Diabetes Wizard EMR-based clinical decision support system [poster]
    2011
  • Changes in cognitive function and plasma biomarkers in a pilot trial of a multi-domain intervention to prevent cognitive decline [poster]
    2010
  • Cost effectiveness of an EMR-based clinical decision support system [poster]
    2010
  • EHR-based clinical decision support for assessing cardiovascular risk [poster]
    2010
  • Health outcomes of bariatric surgery in individuals with type 2 diabetes [poster]
    2010
  • Randomized trial: EHR-based clinical decision support system improved glucose and blood pressure control in diabetes [poster]
    2009
  • Are diabetes patients with depression more likely to get routine care process measures [poster]?
    2008
  • How do the best physicians get diabetes patients to glycemic goals [poster]
    2008
  • Identifying depression among diabetes patients using natural language processing (NLP) of office notes [poster]
    2008
  • Reasons for diabetes clinical inertia in primary care practice [poster]
    2008
  • Using EMR (electronic medical record) data for passive patient safety surveillance in clinical trials [poster]
    2008
  • Using EMR (electronic medical record) data to profile 21 physician-specific treatment strategies in diabetes care [poster]
    2008
  • Depression diagnosis is related to number of outpatient visits in diabetes and non-diabetes patients [poster]
    2007
  • Does comorbid bipolar condition affect diabetes quality of care measures [poster]?
    2007
  • Health plan investments in diabetes care saved money and improved quality [poster]
    2007
  • Should diabetes accountability measures be adjusted for mental health diagnosis? The case of schizophrenia [poster]
    2007
  • Should diabetes quality measures be adjusted for patient depression status [poster]?
    2007
  • Variation in diabetes quality of care across clinics: an assessment using electronic medical record data [poster]
    2007
  • Variation in the efficiency of diabetes care across medical groups in Minnesota [poster]
    2007
  • Wide variation in efficiency of outpatient diabetes care across medical groups [poster]
    2007
  • Are patient experiences of care among adults with diabetes related to health outcomes [poster]?
    2006
  • EMR (Electronic Medical Record) use is not associated with better diabetes care [poster]
    2006
  • Failure of a customized error feedback to improve diabetes care [poster]
    2006
  • Failure of a customized error feedback to improve diabetes care [poster]
    2006
  • Impact of mental health conditions on functional health status in diabetes and heart disease [poster]
    2006
  • Is patient satisfaction related to metabolic control in adults with diabetes [poster]?
    2006
  • Management of adults with chronic kidney disease in primary care: gaps in care [poster]
    2006
  • Patient and physician factors related to intensification of therapy in diabetes patient not at goal [poster]
    2006
  • The association of a mental health diagnosis with metabolic control in diabetes patients [poster]
    2006
  • The association of a mental health diagnosis with metabolic control in diabetes patients [poster]
    2006
  • Variation in the efficiency of diabetes care across medical groups in Minnesota [poster]
    2006
  • When less is more: a randomized trial of a physician intervention to reduce errors in diabetes care [poster]
    2006
  • When less is more: a randomized trial of a physician intervention to reduce errors in diabetes care [poster]
    2006
  • Clinic characteristics that may impact diabetes care outcomes and costs: conceptual approach [poster]
    2005
  • A randomized, controlled diabetes quality improvement study in primary care clinics [poster]
    2003
  • Direct health care costs attributable to physical inactivity and obesity in patients with diabetes, heart disease, both, or neither [poster]
    2003
  • Impact of an electronic medical record on diabetes quality of care [poster]
    2003
  • Improved diabetes care in Minnesota by age and types of diabetes, 1995-2001 [poster]
    2003
  • Improved diabetes care in Minnesota medical groups, 1995-2001 [poster]
    2003
    • Report
  • Leveraging health communication, data, and innovative approaches for sustainable systems-wide changes to reduce the prevalence of obesity: proceedings of a workshop in brief
    2021
  • Stakeholder-driven action plan for improving pain management, opioid use, and opioid use disorder treatment through patient-centered clinical decision support
    2019
  • Healthy lifestyles [health care guideline]
    2011
  • Lipid management in adults [health care guideline]
    2011
  • Prevention and management of obesity [health care guideline]
    2011
  • Hypertension diagnosis and treatment [health care guideline]
    2010
  • Diagnosis and managment of type 2 diabetes mellitus in adults [health care guideline]
    2009
  • Lipid management in adults [health care guideline]
    2009
  • Prevention and management of obesity: mature adolescents and adults [health care guideline]
    2009
  • Primary prevention of chronic disease risk factors [health care guideline]
    2009
  • Diagnosis and managment of type 2 diabetes mellitus in adults [health care guideline]
    2008
  • Hypertension diagnosis and treatment [health care guideline]
    2008
  • Primary prevention of chronic disease risk factors [health care guideline]
    2008
  • Lipid management in adults [health care guideline]
    2006
  • Prevention and management of obesity: mature adolescents and adults [health care guideline]
    2006
    • Review
  • Addressing the diabetes tsunami requires expanded access to diabetes technologies [review]. 
    Journal of Diabetes Science and Technology. 2026
  • Application of continuous glucose monitoring and automated insulin delivery technologies for pregnant women with type 1, type 2, or gestational diabetes: an international consensus statement [review]. 
    The lancet. Diabetes & endocrinology. 2026
  • Challenges in and opportunities for individualising diabetes technology: a position statement by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group [review]. 
    Diabetologia. 2026
  • Challenges in and opportunities for individualizing diabetes technology: a position statement by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group [review]. 
    Diabetes care. 2026
  • Clinical impact of continuous glucose monitoring in noninsulin treated type 2 diabetes: a review [review]. 
    Diabetes Technology & Therapeutics. 2026
  • Continuous ketone monitoring for people with diabetes: international expert recommendations on the application of a new technology [review]. 
    The lancet. Diabetes & endocrinology. 2026
  • Primary care and diabetes technologies and treatments [review]. 
    Diabetes Technology & Therapeutics. 2026
  • Continuous glucose monitoring to guide lifestyle choices with a focus on nutrition in the management of type 2 diabetes: a systematic review and meta-analysis [review]. 
    Journal of Diabetes Science and Technology. 2025
  • Effective strategies for the prevention and mitigation of phosphatidylinositol-3-kinase inhibitor-associated hyperglycemia: optimizing patient care [review]. 
    Clinical Breast Cancer. 2025
  • Evolution of the artificial pancreas: components and integration-CGMs, insulin, and AP systems [review]. 
    Journal of Diabetes Science and Technology. 2025
  • Integrating continuous dual glucose-ketone monitoring into clinical practice [review]. 
    Diabetes Technology & Therapeutics. 2025
  • Primary care and diabetes technologies and treatments [review]. 
    Diabetes Technology & Therapeutics. 2025
  • Registration and real-life studies on automated insulin delivery systems [review]. 
    Diabetes Technology & Therapeutics. 2025
  • Registration and real-life studies on automated insulin delivery systems [review]. 
    Journal of Diabetes Science and Technology. 2025
  • The role of advanced technologies in improving diabetes outcomes [review]. 
    American Journal of Managed Care. 2025
  • The role, potential benefits and cost-effectiveness of digital tools for diabetes management [review]. 
    Clinical Therapeutics. 2025
  • Decreasing the burden of carbohydrate counting and meal announcement with automated insulin delivery, meal recognition, and autocorrection doses: a case study [review]. 
    Diabetes Technology & Therapeutics. 2024
  • Is it time to move beyond TIR to TITR? Real-world data from over 20,000 users of continuous glucose monitoring in patients with type 1 and type 2 diabetes [review]. 
    Diabetes Technology & Therapeutics. 2024
  • Once-weekly insulin efsitora alfa: design and rationale for the QWINT phase 3 clinical development programme [review]. 
    Diabetes, Obesity & Metabolism. 2024
  • Primary care and diabetes technologies and treatments [review]. 
    Diabetes Technology & Therapeutics. 2024
  • Update on measuring ketones [review]. 
    Journal of Diabetes Science and Technology. 2024
  • Use of continuous glucose monitoring when initiating glucagon-like peptide-1 receptor agonist therapy in insulin-treated diabetes [review]. 
    Diabetes, Obesity & Metabolism. 2024
  • Using continuous glucose monitoring data in daily clinical practice [review]. 
    Cleveland Clinic Journal of Medicine. 2024
  • Automated insulin delivery: benefits, challenges, and recommendations. A consensus report of the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes Association [review]. 
    Diabetologia. 2023
  • Biomarkers for the diagnosis of heart failure in people with diabetes: a consensus report from Diabetes Technology Society [review]. 
    Progress in Cardiovascular Diseases. 2023
  • Continuous glucose monitoring and metrics for clinical trials: an international consensus statement [review]. 
    The lancet. Diabetes & endocrinology. 2023
  • Coverage for continuous glucose monitoring for individuals with type 2 diabetes treated with nonintensive therapies: an evidence-based approach to policymaking [review]. 
    Diabetes Technology & Therapeutics. 2023
  • Personalized glycated hemoglobin in diabetes management: closing the gap with glucose management indicator [review]. 
    Diabetes Technology & Therapeutics. 2023
  • Prevalence, cost, and burden of diabetic ketoacidosis [review]. 
    Diabetes Technology & Therapeutics. 2023
  • Primary care and diabetes technologies and treatments [review]. 
    Diabetes Technology & Therapeutics. 2023
  • Automated insulin delivery: benefits, challenges, and recommendations. A consensus report of the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes Association [review]. 
    Diabetes care. 2022
  • Continuous glucose monitoring in primary care - are we there [review]?. 
    Current Opinion in Endocrinology, Diabetes, and Obesity. 2022
  • Flash glucose monitoring in type 2 diabetes managed with basal insulin in the USA: a retrospective real-world chart review study and meta-analysis [meta-analysis]. 
    BMJ open diabetes research & care. 2022
  • Primary care and diabetes technologies and treatments [review]. 
    Diabetes Technology & Therapeutics. 2022
  • Comparison of second-generation basal insulin analogs: a review of the evidence from continuous glucose monitoring [review]. 
    Diabetes Technology & Therapeutics. 2021
  • Primary care and diabetes technologies and treatments [review]. 
    Diabetes Technology & Therapeutics. 2021
  • What's wrong with this picture? A critical review of current Centers for Medicare & Medicaid Services coverage criteria for continuous glucose monitoring [review]. 
    Diabetes Technology & Therapeutics. 2021
  • Diabetes digital app technology: benefits, challenges, and recommendations. A consensus report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group [review]. 
    Diabetes care. 2020
  • Evidence and recommendations on the use of telemedicine for the management of arterial hypertension: an international expert position paper [review]. 
    Hypertension (Dallas, Tex.. 2020
  • HbA1c: the glucose management indicator, time in range, and standardization of continuous glucose monitoring reports in clinical practice [review]. 
    Endocrinology and Metabolism Clinics of North America. 2020
  • Self-monitoring of blood pressure in patients with hypertension-related multi-morbidity: systematic review and individual patient data meta-analysis [meta-analysis, systematic review]. 
    American Journal of Hypertension. 2020
  • The influence of diet interventions using whole, plant food on the gut microbiome: a narrative review [review]. 
    Journal of the Academy of Nutrition and Dietetics. 2020
  • The role of blood glucose monitoring in diabetes management [review]
    2020
  • Advanced technology in the management of diabetes: which comes first-continuous glucose monitor or insulin pump [review]?. 
    Current Diabetes Reports. 2019
  • Advances in technology for management of type 1 diabetes [review]. 
    Lancet (London, England). 2019
  • Clinical targets for continuous glucose monitoring data interpretation: recommendations from the International Consensus on Time-in-Range [review]. 
    Diabetes care. 2019
  • Priorities Wizard: multisite web-based primary care clinical decision support improved chronic care outcomes with high use rates and high clinician satisfaction rates [review]. 
    EGEMS (Washington, DC). 2019
  • Utilizing the ambulatory glucose profile to standardize and implement continuous glucose monitoring in clinical practice [review]. 
    Diabetes Technology & Therapeutics. 2019
  • Approach to using trend arrows in the freestyle libre flash glucose monitoring systems in adults [review]. 
    Journal of the Endocrine Society. 2018
  • Clinical use of continuous glucose monitoring in adults with type 2 diabetes [review]. 
    Diabetes Technology & Therapeutics. 2017
  • Improving the clinical value and utility of CGM systems: issues and recommendations: a joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group [review]. 
    Diabetologia. 2017
  • Improving the clinical value and utility of CGM systems: issues and recommendations: a joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group [review]. 
    Diabetes care. 2017
  • International consensus on use of continuous glucose monitoring [review]. 
    Diabetes care. 2017
  • Role of continuous glucose monitoring in clinical trials: recommendations on reporting [review]. 
    Diabetes Technology & Therapeutics. 2017
  • Self-monitoring of blood pressure in hypertension: A systematic review and individual patient data meta-analysis [review, systematic review, meta-analysis]. 
    PLoS Medicine. 2017
  • Outpatient diabetes clinical decision support: current status and future directions [review]. 
    Diabetic Medicine. 2016
  • Diagnostic and predictive accuracy of blood pressure screening methods with consideration of rescreening intervals: a systematic review for the U.S. Preventive Services Task Force [review, systematic review]. 
    Annals of Internal Medicine. 2015
  • Screening for high blood pressure in adults: a systematic evidence review for the U.S. Preventive Services Task Force [review]
    2014
  • Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) [review]. 
    Diabetes care. 2012
  • The safety of incretin-based therapies--review of the scientific evidence [review]. 
    Journal of Clinical Endocrinology and Metabolism. 2011
  • Type 2 diabetes: assessing the relative risks and benefits of glucose-lowering medications [review]. 
    American Journal of Medicine. 2010
  • Clinical application of incretin-based therapy: therapeutic potential, patient selection and clinical use [review]. 
    European Journal of Internal Medicine. 2009
  • Clinical application of incretin-based therapy: therapeutic potential, patient selection and clinical use [review]. 
    American Journal of Medicine. 2009
  • Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA Diabetes Trials: a position statement of the American Diabetes Association and a Scientific Statement of the American College of Cardiology Foundation and the American Heart Association [review]. 
    Journal of the American College of Cardiology. 2009
  • Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association [review]. 
    Circulation. 2009
  • Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association [review]. 
    Diabetes care. 2009
  • Preventing and managing cardiometabolic risk: the logic for intervention [review]. 
    International Journal of Environmental Research and Public Health. 2009
  • A new look at screening and diagnosing diabetes mellitus [review]. 
    Journal of Clinical Endocrinology and Metabolism. 2008
  • Clinical application of emerging sensor technologies in diabetes management: consensus guidelines for continuous glucose monitoring (CGM) [review]. 
    Diabetes Technology & Therapeutics. 2008
  • Restricted-carbohydrate diets in patients with type 2 diabetes: a meta-analysis [meta-analysis, review]. 
    Journal of the American Dietetic Association. 2008
  • Prevention of cardiovascular disease in persons with type 2 diabetes mellitus: current knowledge and rationale for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial [review]. 
    American Journal of Cardiology. 2007
  • Clinical inertia and outpatient medical errors [review]
    2005
  • Identification, classification, and frequency of medical errors in outpatient diabetes care [review]
    2005
  • The role of self-monitoring of blood glucose in the care of people with diabetes: report of a global consensus conference [review]. 
    American Journal of Medicine. 2005
  • Comprehensive management of patients with type 2 diabetes: establishing priorities of care [review]. 
    American Journal of Managed Care. 2001
  • Intensified diabetes management: lessons from the diabetes control and complications trial [review]. 
    International Journal of Clinical Pharmacology and Therapeutics. 1995
    • Abstract
  • Evaluation of race and ethnicity and pharmacy dispensing of sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists in patients with type 2 diabetes [abstract]. 
    Circulation. 2024
  • Comparing change in systolic blood pressure with clinic-based care versus telehealth care in a pragmatic cluster-randomized trial (Hyperlink 3) [abstract]. 
    Journal of patient-centered research and reviews. 2021
  • Maximizing use of chronic disease clinical decision support in primary care clinics: lessons learned from randomized trials [abstract]. 
    Journal of patient-centered research and reviews. 2021
  • Patients deciding on cancer screening and prevention using clinical decision support: "I wouldn't have thought about getting screened without it" [abstract]. 
    Journal of patient-centered research and reviews. 2021
  • Better care strategies are necessary to address poor medication adherence [abstract]. 
    Diabetes. 2020
  • Change in A1C with and without intermittent use of CGM in adults with type 2 diabetes participating in the Onduo Virtual Diabetes Clinic [abstract]. 
    Diabetes. 2020
  • Cross-study comparisons done right: an illustration using two pivotal trials of closed-loop systems [abstract]. 
    Diabetes. 2020
  • Derived time-in-range is associated with MACE in T2D: data from the DEVOTE Trial [abstract]. 
    Diabetes. 2020
  • First home evaluation of the Omnipod Horizon automated glucose control system at specific glucose targets in children with type 1 diabetes [abstract]. 
    Diabetes. 2020
  • Freestyle Libre system use is associated with reduction in inpatient and outpatient emergency acute diabetes events and all-cause hospitalizations in patients with type 2 diabetes [abstract]. 
    Diabetes. 2020
  • Glycemic relapse: major threat to ongoing improvement in diabetes care [abstract]. 
    Diabetes. 2020
  • Patient-reported outcomes for 2,335 adults with type 2 diabetes using the omnipod insulin management system show glycemic improvement over first 90 days of use [abstract]. 
    Diabetes. 2020
  • Patients’ interpretation of Ambulatory Glucose Profile (AGP), CGM, and pump reports [abstract]. 
    Diabetes. 2020
  • Safety and glycemic outcomes of the MiniMed advanced hybrid closed-loop (AHCL) system in subjects with T1D [abstract]. 
    Diabetes. 2020
  • Ultra-Rapid Lispro (URLi) demonstrates similar time-in-target range to Humalog with the Medtronic MiniMed 670G Hybrid Closed-Loop System [abstract]. 
    Diabetes. 2020
  • Utilization of continuous glucose monitors is associated with reduction in inpatient and outpatient emergency acute diabetes events regardless of prior blood test strip usage [abstract]. 
    Diabetes. 2020
  • A web-based clinical decision support system (Wizard) increases appropriate cardiometabolic diagnostic coding at primary care visits [abstract]. 
    Journal of patient-centered research and reviews. 2019
  • Blood pressure checks and diagnosing hypertension (BP-CHECK): a randomized controlled diagnostic study comparing clinic, home, and kiosk, to 24-hour ambulatory BP monitoring--comparative accuracy primary outcome results [abstract]. 
    Journal of patient-centered research and reviews. 2019
  • Challenges encountered in linking community health centers' electronic health record data to a web-based clinical decision support tool [abstract]. 
    Journal of patient-centered research and reviews. 2019
  • Dissemination and sustained use of an outpatient clinical decision system with high use rates, high clinician satisfaction, and positive impact on quality of care [abstract]. 
    Journal of patient-centered research and reviews. 2019
  • Long-term effects on cardiovascular events of home blood pressure telemonitoring with pharmacist management in patients with uncontrolled hypertension [abstract]. 
    Journal of patient-centered research and reviews. 2019
  • Variation in care improvement opportunities suggests need for tailored clinician-specific improvement interventions [abstract]. 
    Journal of patient-centered research and reviews. 2019
  • A comparison of the impact of the 2017 ACC/AHA hypertension guidelines on primary care populations with and without diabetes [abstract]. 
    Diabetes. 2018
  • Impact of human versus analog insulins on occurrence of myocardial infarction [abstract]. 
    Diabetologia. 2017
  • A clinical decision support system promotes shared decision-making and cardiovascular risk factor management [abstract]. 
    Journal of patient-centered research and reviews. 2016
  • All is not equal...or is it? Targeting uncontrolled cardiovascular risk factors in racial and ethnic populations to prevent major cardiovascular events [abstract]. 
    Diabetologia. 2016
  • Alogliptin in triple therapy with metformin and sulfonylureas provides significant reductions in HbA1c and is well tolerated: an analysis from the EXAMINE Trial [abstract]. 
    Diabetes. 2016
  • Can financial incentives prevent diabetes in a low-income population? [abstract]. 
    Diabetes. 2016
  • Comparative effectiveness of two diabetes clinical decision support systems on cardiometabolic outcomes and CV risk: randomized trial [abstract 2304-PUB]. 
    Diabetes. 2016
  • Design features of successful outpatient chronic disease care clinical decision support systems [abstract]. 
    Journal of patient-centered research and reviews. 2016
  • Designing outpatient diabetes care clinical decision support systems for high use rates [abstract 2309-PUB]. 
    Diabetes. 2016
  • Double-blind mealtime faster-acting insulin aspart vs. insulin aspart in basal-bolus improves glycemic control in T1D: the Onset 1 Trial [abstract #293-OR]. 
    Diabetes. 2016
  • Effect of empagliflozin on nephropathy in subgroups by age: results from EMPA-REG outcome [abstract 1198-P]. 
    Diabetes. 2016
  • Efficacy and safety of LixiLan vs. insulin glargine according to baseline characteristics in patients with type 2 diabetes from the LixiLan-L Trial [abstract 1018-P]. 
    Diabetes. 2016
  • Efficacy and safety of the insulin glargine plus lixisenatide fixed-ratio combination vs. insulin glargine in patients wth T2DM: the LixiLan-L trial [abstract]. 
    Diabetes. 2016
  • Eliciting patient treatment preferences using a clinical decision support system [abstract 1252-P]. 
    Diabetes. 2016
  • Hypoglycemia is associated with increased risk of cardiovascular events: results from the EXAMINE Trial [abstract]. 
    Diabetes. 2016
  • Long-term impact of intensive glucose, blood pressure, or lipid control on health utility: ACCORDION Study [abstract]. 
    Diabetes. 2016
  • Mortality findings from the EXAMINE Trial [abstract]. 
    Diabetes. 2016
  • Novel pattern identification through standardized data display using the ambulatory glucose profile (AGP) report [abstract]. 
    Diabetes Technology & Therapeutics. 2016
  • Overuse and underuse of acetyl-salicylic acid for primary prevention of cardiovascular disease in people with diabetes [abstract]. 
    Diabetologia. 2016
  • Overuse and underuse of aspirin for primary prevention [abstract 1225-P]. 
    Diabetes. 2016
  • Overuse and underuse of aspirin for primary prevention of cardiovascular events in primary care [abstract]. 
    Journal of patient-centered research and reviews. 2016
  • Qualitative data from a trial of home blood pressure telemonitoring and pharmacist management (Hyperlink) [abstract]. 
    Journal of patient-centered research and reviews. 2016
  • Randomised trial of a diabetes clinical decision support system: use rates, provider satisfaction, and impact on clinical outcomes [abstract]. 
    Diabetologia. 2016
  • Use and customization of risk scores for predicting cardiovascular events using electronic health record data [abstract]. 
    Journal of patient-centered research and reviews. 2016
  • Are composite measures of diabetes quality of care associated with major CV events [abstract 440-P]?. 
    Diabetes. 2015
  • Disseminating web-based EHR-linked diabetes clinical decision support system from one medical group to another: case study [abstract 1377-P]. 
    Diabetes. 2015
  • Early response to liraglutide 3.0 mg in adults with overweight or obesity and type 2 diabetes: subanalysis of the SCALE Diabetes Trial [abstract]. 
    Diabetes. 2015
  • Evaluation of provider experience with an EHR-based clinical decision support tool [abstract]. 
    Diabetes. 2015
  • Glucose variability in type 2 diabetes: the initial results of the FLAT-SUGAR trial [abstract 385-OR]. 
    Diabetes. 2015
  • Glycemic variability correlated with 1.5-anhydroglucitol (1.5 AHG) but not with markers of oxidation, inflammation, and endothelial function: baseline characteristics of the CAROLINA CGM sub-study [abstract]. 
    Diabetes. 2015
  • How to minimize future CV events and total mortality in adults with diabetes: lessons from the 10,000,000 person-year SUPREME Cohort Study [abstract]. 
    Diabetes. 2015
  • Hypoglycemia and glucose variability in older adults with type 1 diabetes (T1D) [abstract 408-P]. 
    Diabetes. 2015
  • Major cardiovascular outcomes in the EXAMINE trial according to ACE inhibitor use [abstract]. 
    Diabetes. 2015
  • Severe hypoglycemia in a large cohort of adults with diabetes mellitus treated in U.S. integrated health care delivery systems, 2005-2011 [abstract 390-P]. 
    Diabetes. 2015
  • Superior reduction of HbA1c in a double-blind, randomized study of basal insulin peglispro (BIL) vs. insulin glargine (GL) in patients (pts) with T1D: IMAGINE 3 [abstract]. 
    Diabetes. 2015
  • Surveillance of cardiovascular events and total mortality among insured adults with and without diabetes: the SUPREME Cohort Study [abstract 55-OR]. 
    Diabetes. 2015
  • Sustained use of a diabetes clinical decision support tool in primary care practices [abstract]. 
    Diabetes. 2015
  • Trends in diabetes control and insulin use in the U.S., 1998-2010 [abstract]. 
    Diabetes. 2015
  • Understanding patient and clinician glucose reporting preferences in type 1 diabetes: Ambulatory Glucose Profile (AGP) [abstract]. 
    Diabetologia. 2015
  • Educating resident physicians using virtual case-based simulation improves diabetes management--a randomized, controlled trial [abstract 322-OR]. 
    Diabetes. 2014
  • Improving mental health and diabetes management with mindfulness-based stress reduction [abstract] [presentation]
    2014
  • Randomized trial of telephone outreach to improve medication adherence and metabolic control in adults with diabetes [abstract]. 
    Diabetes. 2014
  • Aspirin decision support using data-driven treatment algorithms [abstract]. 
    Clinical Medicine & Research. 2013
  • Costs associated with delivering intensive or standard glucose, lipids, and systolic blood pressure control strategies in the ACCORD Trial [abstract]. 
    Diabetes. 2013
  • Glucose screening and identification of pre-diabetes in children and adolescents 2007-2011 [abstract]. 
    Diabetes. 2013
  • Outcomes of a randomized trial of home blood pressure telemonitoring with pharmacist case management [abstract]. 
    Clinical Medicine & Research. 2013
  • Recidivism to uncontrolled BP levels in previously controlled hypertension patients [abstract]. 
    Clinical Medicine & Research. 2013
  • Testing a clinical decision support process to lower cardiovascular risk of patients [abstract]. 
    Clinical Medicine & Research. 2013
  • Virtual diabetes education improves resident physician knowledge and performance: a cluster randomized trial [abstract]. 
    Clinical Medicine & Research. 2013
  • Virtual diabetes education improves resident physician knowledge and performance: a cluster-randomized trial [abstract]. 
    Diabetes. 2013
  • A simulated diabetes learning intervention improves provider knowledge and confidence in managing diabetes [abstract]. 
    Clinical Medicine & Research. 2012
  • Diabetes prevalence among 2.4 million health maintenance organisation (HMO) members < 20 years of age, 2005-2009: the SUPREME-DM project [abstract]. 
    Diabetologia. 2012
  • Intensive glucose, blood pressure, or lipid control had no significant negative impact on health utility or quality-adjusted life years in the ACCORD Trial [abstract]. 
    Diabetes. 2012
  • Prevalence of HT in children: comparison between task force recommendations and average of multiple measurements over 2 or 4 years [abstract]. 
    Clinical Medicine & Research. 2012
  • Prevalence of elevated blood pressure and BMI in U.S. children and adolescents [abstract]. 
    Clinical Medicine & Research. 2012
  • Primary care residents highly rate simulated diabetes training [abstract]. 
    Clinical Medicine & Research. 2012
  • Simulated diabetes training helps providers bring patients to goals: a cluster randomized trial [abstract]. 
    Diabetes. 2012
  • Simulated training improves provider knowledge and confidence in managing diabetes [abstract]. 
    Diabetes. 2012
  • Use of electronic health records to estimate 5-year incidence of diabetes among health maintenance organization (HMO) members <20 years of age: the SUPREME-DM Project [abstract]. 
    Pediatric Diabetes. 2012
  • Adherence to comprehensive interventions for management of uncontrolled hypertension [abstract]. 
    Journal of Clinical Hypertension (Greenwich, Conn.). 2011
  • Early initiation of metformin in new-onset type 2 diabetes [abstract]. 
    Diabetes. 2011
  • Effect of intensive versus standard blood pressure control on health-related quality of life in type 2 diabetes mellitus: ACCORD Trial [abstract 47-OR]. 
    Diabetes. 2011
  • Impact of bariatric surgery on long-term remission and relapse of type 2 diabetes mellitus: multi-site study [abstract 1190-P]. 
    Diabetes. 2011
  • Intensive blood pressure control does not increase falls and fractures in patients with type 2 diabetes: the ACCORD trial [abstract]. 
    Journal of Clinical Hypertension (Greenwich, Conn.). 2011
  • Intensive glycemic control and fracture risk [abstract 1352-P]. 
    Diabetes. 2011
  • Intensive glycemic control not linked to falls in ACCORD [abstract]. 
    Diabetes. 2011
  • Major depression predicts total mortality in ACCORD trial participants [abstract 48-OR]. 
    Diabetes. 2011
  • Microvascular effects of intensive blood pressure control and its relation to glycaemic control in the ACCORD blood pressure trial [abstract]. 
    Diabetologia. 2011
  • Overweight and obesity in those age 3-17 years old: implications for diabetes prevention [abstract 2377-PO]. 
    Diabetes. 2011
  • Personalization of care for type 2 diabetes: a process control approach [abstract]. 
    Diabetes. 2011
  • Prioritization of treatment and its consequences: implications of accountability measures [abstract 46-OR]. 
    Diabetes. 2011
  • A diabetes simulated physician learning program improved glucose control and is highly cost-effective [abstract]. 
    Diabetes. 2010
  • A new approach to CME? A simulated physician learning program improves glucose control in adults with diabetes [abstract]. 
    Diabetes. 2010
  • Changes in physical activity and nutrition in a behavioral intervention pilot study - passport to brain wellness [abstract]. 
    Clinical Medicine & Research. 2010
  • Cost-effectiveness of an EMR-based diabetes clinical decision support system [abstract]. 
    Diabetes. 2010
  • Disease management strategies to optimize cardiovascular risk in type 2 diabetes mellitus [abstract]. 
    Clinical Medicine & Research. 2010
  • EMR-based clinical decision support system improved glucose and blood pressure control in adults with diabetes [abstract]. 
    Clinical Medicine & Research. 2010
  • Effect of point-of-care A1c testing in primary care clinics on diabetes medication intensification [abstract]. 
    Clinical Medicine & Research. 2010
  • Enhancing long-term weight loss maintenance: Keep It Off trial design and baseline data [abstract]. 
    Annals of Behavioral Medicine. 2010
  • Home blood pressure telemonitoring and case management to control hypertension: HyperLink trial design and baseline characteristics [abstract]. 
    Clinical Medicine & Research. 2010
  • Home blood pressure telemonitoring and case management to control hypertension: hyperlink design, baseline characteristics, and intervention adherence [abstract]. 
    Journal of Clinical Hypertension (Greenwich, Conn.). 2010
  • How do the best physicians get diabetes patients to glycemic goals [abstract]?. 
    Clinical Medicine & Research. 2010
  • Hypertension treatment intensification and BP control in adults with and without diabetes [abstract]. 
    Diabetes. 2010
  • Identifying physician decision stretegies for treating patients with type 2 diabetes [abstract]. 
    Diabetes. 2010
  • Personalized learning intervention to enhance hypertension care skills of physicians and extended-care providers [abstract]. 
    Diabetes. 2010
  • Personalized physician learning intervention improved glucose control in adults with diabetes [abstract]. 
    Clinical Medicine & Research. 2010
  • Racial disparities in A1c change and medication intensification [abstract]. 
    Clinical Medicine & Research. 2010
  • Readiness of U.S. health plans to manage cardiometabolic risk [abstract]. 
    Clinical Medicine & Research. 2010
  • Standardized vs personalized diabetes care goals: implications for guidelines, decision support, and accountability measures [abstract]. 
    Diabetes. 2010
  • Towards lower macrovascular risk in diabetes patients: a simulation-based evaluation of prioritization strategies [abstract]. 
    Diabetes. 2010
  • Use of complementary and alternative medicine in people with diabetes [abstract]. 
    Annals of Behavioral Medicine. 2010
  • Validation of self-reported diabetes from the Women’s Health Initiative (WHI) clinical trials [abstract]. 
    Clinical Medicine & Research. 2010
  • Validation of the SimCare model: a computational model of individual patients with type 2 diabetes [abstract]. 
    Diabetes. 2010
  • Clinical decision support delivered through EMRs improved glucose and blood pressure control in adults with diabetes [abstract]. 
    Diabetologia. 2009
  • Disease management strategies to optimize cardiovascular risk in type 2 diabetes mellitus [abstract]. 
    Diabetes. 2009
  • EMR-based clinical decision support system improved glucose and blood pressure control in adults with diabetes [abstract]. 
    Diabetes. 2009
  • How do the best physicians get diabetes patients to glycemic goals [abstract]?. 
    Diabetes. 2009
  • Personalized physician learning intervention improved glucose control in adults with diabetes [abstract]. 
    Diabetes. 2009
  • Are diabetes patients with depression more likely to get routine care process measures [abstract]?. 
    Diabetes. 2008
  • Association of lean mass and fat mass with bone mineral density in older diabetic adults: the ACCORD-BONE study [abstract]. 
    Diabetes. 2008
  • How do the best physicians get diabetes patients to glycemic goals [abstract]?. 
    Diabetes. 2008
  • Implementation of electronic decision support for providers to improve diabetes care [abstract]. 
    Diabetes. 2008
  • Reasons for diabetes clinical inertia in primary care practice [abstract]. 
    Diabetes. 2008
  • The anatomy of clinical inertia: using EMR-derived data to profile 21 physician-specific medication treatment strategies in diabetes care [abstract]. 
    Diabetes. 2008
  • Using EMR (electronic medical record) data for passive patient safety surveillance in clinical trials [abstract]. 
    Diabetes. 2008
  • Using natural language processing (NLP) to identify depression in diabetes patients [abstract]. 
    Diabetes. 2008
  • Association of diabetes and schizophrenia in a health plan population [abstract]. 
    Biological Psychiatry. 2007
  • Association of diabetes and schizophrenia in a health plan population [abstract]. 
    Diabetes. 2007
  • Does diabetes double the risk of depression? Understanding the impact of visit frequency [abstract]. 
    Diabetes. 2007
  • EMR (Electronic Medical Record) is not associated with better diabetes care [abstract]. 
    Diabetes. 2007
  • Enhanced primary care for adults with diabetes saved money and improved health [abstract]. 
    Diabetes. 2007
  • Impact of bipolar condition on diabetes care in adults [abstract]. 
    Biological Psychiatry. 2007
  • Impact of bipolar condition on diabetes care in adults [abstract]. 
    Diabetes. 2007
  • Impact of schizophrenia diagnosis on diabetes care in adults [abstract]. 
    Diabetes. 2007
  • Improved diabetes care using a single comprehensive diabetes quality measure: the Minnesota experience [abstract]. 
    Diabetes. 2007
  • Is severity of depression related to glycemic control in adults with diabetes mellitus [abstract]?. 
    Biological Psychiatry. 2007
  • Is severity of depression related to glycemic control in adults with diabetes mellitus [abstract]?. 
    Diabetes. 2007
  • Using EMR (Electronic Medical Record) to assess variation in diabetes care quality of care across clinics and physicians [abstract]. 
    Diabetes. 2007
  • Variation in the efficiency of diabetes care across medical groups [abstract]. 
    Diabetes. 2007
  • Impact of spiritual and religious beliefs and practices on clinical measures of diabetes care in adults [abstract]. 
    Diabetes. 2006
  • Is patient satisfaction related to metabolic control in adults with diabetes [abstract]. 
    Diabetes. 2006
  • Patient and physician factors related to intensification of therapy in diabetes patient not at goal [abstract]. 
    Diabetes. 2006
  • Is patient readiness to change a predictor of improved glycemic control [abstract]. 
    Diabetes. 2004
  • Randomized trial of a quality improvement intervention to improve diabetes care in primary care practices [abstract]. 
    Diabetes. 2004
  • Relative impact of glycemic control and cardiovascular comorbidity on subsequent resource use among adults with diabetes [abstract]. 
    Diabetes. 2004
  • The impact of clinic and medical group characteristics on diabetes care outcomes in primary care clinics [abstract]. 
    Diabetes. 2004
  • Decisional balance and physical activity predict body mass index among sedentary adults and seniors [abstract]. 
    Medicine and Science in Sports and Exercise. 2003
    • Audio Document
  • CGM use in type 2 diabetes
    2018
    • Audio-Visual Document
  • Practice vs accountability in diabetes care
    2011
    • Book
  • Lipid management in adults [health care guideline]
    2007
  • Management of type 2 diabetes mellitus [health care guideline]
    2006
  • Lipid management in adults [healthcare guideline]
    2005
    • Patent
  • Methods for treating patients with impaired awareness of hypoglycemia
    2021
  • Treatment of hypoglycemia unawareness with intranasal insulin
    2017
    • Webpage
  • Will the surge in new diabetes devices improve patient outcomes?
    2020
    • Quick Info